<SEC-DOCUMENT>0001213900-24-107009.txt : 20241209
<SEC-HEADER>0001213900-24-107009.hdr.sgml : 20241209
<ACCEPTANCE-DATETIME>20241209170624
ACCESSION NUMBER:		0001213900-24-107009
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20241205
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241209
DATE AS OF CHANGE:		20241209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BTC Digital Ltd.
		CENTRAL INDEX KEY:			0001796514
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39258
		FILM NUMBER:		241535909

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, TOWER A, 2 SHENYUN ROAD WEST
		STREET 2:		NANSHAN DISTRICT, GUANGDONG PROVINCE
		CITY:			SHENZHEN
		STATE:			F4
		ZIP:			518000
		BUSINESS PHONE:		0118675582945250

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, TOWER A, 2 SHENYUN ROAD WEST
		STREET 2:		NANSHAN DISTRICT, GUANGDONG PROVINCE
		CITY:			SHENZHEN
		STATE:			F4
		ZIP:			518000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DTC Digital Ltd.
		DATE OF NAME CHANGE:	20230816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Meten Holding Group Ltd.
		DATE OF NAME CHANGE:	20210901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Meten EdtechX Education Group Ltd.
		DATE OF NAME CHANGE:	20191211
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0224043-8k_btcdigi.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:BTCT="http://btct.investorroom.com/20241205">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_BTCT_btct.investorroom.com_20241205 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20241205_20241205 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001796514 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000004" name="dei:EntityCentralIndexKey">0001796514</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-05" id="xdx2ixbrl0014" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="btct-20241205.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-12-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001796514</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-05</xbrli:startDate>
        <xbrli:endDate>2024-12-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-052024-12-05_custom_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001796514</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCT:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-05</xbrli:startDate>
        <xbrli:endDate>2024-12-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-052024-12-05_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001796514</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCT:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-05</xbrli:startDate>
        <xbrli:endDate>2024-12-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_90D_edei--DocumentType_c20241205__20241205_zAuiRpj61YZf"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF<br/>
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):
December 9, 2024 (<span id="xdx_907_edei--DocumentPeriodEndDate_c20241205__20241205_z0EX7JO3NoQ1"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 5, 2024</ix:nonNumeric></span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_900_edei--EntityRegistrantName_c20241205__20241205_zwkAA8V9oTd1"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000011" name="dei:EntityRegistrantName">BTC DIGITAL LTD.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of Company as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20241205__20241205_zSCUF0o20Uml"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt-sec:edgarprovcountryen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20241205__20241205_zM1c0erWkEUa"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000013" name="dei:EntityFileNumber">001-39258</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_dxL_c20241205__20241205_zgdcx98qKVv" title="::XDX::00-0000000"><span style="-sec-ix-hidden: xdx2ixbrl0014">N/A</span></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20241205__20241205_znwcOmLmyoE1"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000015" name="dei:EntityAddressAddressLine1">61 Robinson Road Level 6 &amp; 7</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_905_edei--EntityAddressAddressLine2_c20241205__20241205_zt4yLZhmMO89"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000016" name="dei:EntityAddressAddressLine2">#738</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressCountry_c20241205__20241205_zlOvwo0eqFbd"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt-sec:countrynameen" id="Fact000017" name="dei:EntityAddressCountry">Singapore</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressPostalZipCode_c20241205__20241205_zqXzaJgXlKWh"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000018" name="dei:EntityAddressPostalZipCode">068893</ix:nonNumeric> </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90E_edei--CityAreaCode_c20241205__20241205_zTzfnvbqPwud"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000019" name="dei:CityAreaCode">+65</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20241205__20241205_zqR0piyMsE0h"><ix:nonNumeric contextRef="AsOf2024-12-05" id="Fact000020" name="dei:LocalPhoneNumber">6022 2515</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(<span style="background-color: white">Registrant&#8217;s
telephone number including area code</span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20241205__20241205_zItxi0Jjjuok"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SolicitingMaterial_c20241205__20241205_z858V1ahPoQ7"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20241205__20241205_zl4cucsqXIM4"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20241205__20241205_zO2QC2DWhyG1"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20241205__20241205_z8WBfXy1nkb6"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleantrue" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_908_edei--EntityExTransitionPeriod_c20241205__20241205_zpAriadIbb8b"><ix:nonNumeric contextRef="AsOf2024-12-05" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_z2pqzknYU2Ak"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember" id="Fact000027" name="dei:Security12bTitle">Ordinary Shares</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zZkbCU20SQw8"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember" id="Fact000028" name="dei:TradingSymbol">BTCT</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90D_edei--SecurityExchangeName_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zVnM1kOES6Z8"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zX5y8WYIU9yj"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_WarrantsMember" id="Fact000030" name="dei:Security12bTitle">Warrants</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zlGunuEdkD74"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_WarrantsMember" id="Fact000031" name="dei:TradingSymbol">BTCTW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90A_edei--SecurityExchangeName_c20241205__20241205__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zUWsBO4oND8c"><ix:nonNumeric contextRef="From2024-12-052024-12-05_custom_WarrantsMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01. Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2024, BTC Digital Ltd. (the &#8220;Company&#8221;)
entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Aegis Capital Corp. (the &#8220;Underwriter&#8221;),
as amended by a written amendment on December 9, 2024, relating to the Company&#8217;s public offering (the &#8220;Offering&#8221;) of
880,000 shares (the &#8220;Shares&#8221;) of its ordinary shares, par value $0.06 per share (&#8220;Ordinary Shares&#8221;), and pre-funded
warrants to purchase 1,620,000 shares of Ordinary Shares in lieu of Ordinary Shares (the &#8220;Pre-Funded Warrants&#8221;, and collectively
with the Shares, the &#8220;Firm Securities&#8221;) to certain investors. Pursuant to the Underwriting Agreement, the Company also granted
the Underwriters a 45-day option (&#8220;Option&#8221;) to purchase an additional 375,000 shares of Ordinary Shares (the &#8220;Option
Securities&#8221;, and together with the Firm Securities, the &#8220;Securities&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 9, 2024, the Company issued the Firm
Securities and closed the Offering at a public price of $8.00 per Share, and $7.999 per share underlying each Pre-Funded Warrant, for
net proceeds to the Company of approximately $18.40 million after deducting underwriting discounts and commissions and estimated offering
expenses payable by the Company. The Company intends to use the net proceeds of the Offering for general corporate purposes, which may
include increasing its working capital, reducing indebtedness as applicable, acquisitions or investments in businesses, products or technologies
that are complementary to its own, and capital expenditures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Pre-Funded Warrant has an exercise price
per share of Ordinary Shares equal to $0.001 per share. The exercise price and the number of shares of Ordinary Shares issuable upon exercise
of each Pre-Funded Warrant is subject to adjustments in the event of certain stock dividends and distributions, stock splits, stock combinations,
reclassifications or similar events affecting the Ordinary Shares. Under the Pre-Funded Warrants, a holder will not be entitled to exercise
any portion of any Pre-Funded Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares of Ordinary
Shares beneficially owned by such holder (together with its affiliates) to exceed 4.99% of the number of shares of Ordinary Shares outstanding
immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded
Warrant, which percentage may be changed at the holder&#8217;s election to a higher or lower percentage not in excess of 9.99% upon 61
days&#8217; notice to the Company. In addition, in certain circumstances, upon a fundamental transaction, a holder of Pre-Funded Warrants
will be entitled to receive, upon exercise of the Pre-Funded Warrants, the kind and amount of securities, cash or other property that
such holder would have received had they exercised the Pre-Funded Warrants immediately prior to the fundamental transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Firm Securities were offered, issued, and
sold pursuant to a prospectus supplement and accompanying prospectus filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
pursuant to an effective shelf registration statement filed with the SEC on Form S-3 (File No. 333-283367) (the &#8220;Registration Statement&#8221;)
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), as supplemented by a prospectus supplement, dated December
6, 2024, relating to the Securities (together with the accompanying base prospectus, dated November 20, 2024, the &#8220;Prospectus Supplement&#8221;),
filed with the SEC pursuant to Rule 424(b) of the Securities Act on December 9, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underwriting Agreement includes customary
representations, warranties, and agreements by the Company, customary conditions to closing, indemnification obligations of the Company
and the Underwriter, including for liabilities under the Securities Act, other obligations of the parties and termination provisions.
The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of the Underwriting
Agreement and as of the specific applicable dates contained in the Underwriting Agreement, were solely for the benefit of the parties
to the Underwriting Agreement and were subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underwriting Agreement, the Form of Pre-Funded
Warrant, and the amendment to the Underwriting Agreement are filed as Exhibit 1.1, Exhibit 4.1, and Exhibit 99.1 to this report and are
each incorporated herein by reference, respectively. The foregoing is only a brief description of the terms of the Underwriting Agreement
and the Pre-Funded Warrant and does not purport to be a complete statement of the rights and obligations of the parties thereto and the
transactions contemplated thereby, and each are qualified in their entirety by reference to the full text of such each such exhibit. A
copy of the legal opinions of Conyers Dill &amp; Pearman, relating to the validity of the issuance and sale of the Shares and the Pre-Funded
Warrants in the Offering, is filed as Exhibit 5.1 to this Current Report on Form 8-K and is filed with reference to, and is hereby incorporated
by reference into, the Registration Statement.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01 Other Events.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 5, 2024, the Company issued a press
release announcing the launch of the Offering. The press release is attached as Exhibit 99.2 to this report and is incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2024, the Company issued a press
release announcing the pricing of the Offering. The press release is attached as Exhibit 99.3 to this report and is incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 9, 2024, the Company issued a press
release announcing the closing of the Offering. The press release is attached as Exhibit 99.4 to this report and is incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cautionary Note Regarding Forward Looking
Statements</i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Current Report on Form&#160;8-K&#160;contains
forward-looking statements, including statements regarding the Offering, including, without limitation, the Company&#8217;s intended use
of proceeds from the Offering, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements are commonly identified by words such as &#8220;will be,&#8221; &#8220;may,&#8221; &#8220;expects,&#8221;
&#8220;believes,&#8221; &#8220;plans&#8221; and &#8220;intends&#8221; and other terms with similar meaning. You are cautioned that the
forward-looking statements in this Current Report on Form&#160;8-K&#160;are based on current beliefs, assumptions and expectations, speak
only as of the date of this Current Report on Form&#160;8-K&#160;and involve risks and uncertainties that could cause actual results to
differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of
which are difficult to predict and generally beyond the Company&#8217;s control, that could cause actual results and other future events
to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors
that could cause actual results to differ materially from current expectations include, without limitation, market conditions and the
risk factors detailed in the Prospectus Supplement, which is a part of the Registration Statement, the Company&#8217;s Quarterly Report
on Form&#160;10-Q&#160;for the quarter ended September 30, 2024, and those risk factors set forth from time to time in the Company&#8217;s
other filings with the SEC. For the reasons discussed above, you should not place undue reliance on the forward-looking statements in
this Current Report on Form&#160;8-K.&#160;The Company undertakes no obligation to update the forward-looking statements set forth in
this Current Report on Form&#160;8-K,&#160;whether as a result of new information, future events or otherwise, unless required by applicable
securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statement and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><a href="ea022404301ex1-1_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated December 6, 2024, between BTC Digital Ltd. and Aegis Capital Corp.</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex4-1_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-funded Warrant</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex5-1_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Conyers Dill &amp; Pearman</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex5-1_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Conyers Dill &amp; Pearman (included in Exhibit 5.1)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex99-1_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to the Underwriting Agreement, dated December 9, 2024</span></a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex99-2_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated December 5, 2024</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">99.3</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex99-3_btcdigi.htm">Press Release, dated December 6, 2024</a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="ea022404301ex99-4_btcdigi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated December 9, 2024</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">104</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cover
                                            Page Interactive Data File (embedded within the Inline XBRL document)</p>
</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BTC Digital Ltd.</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 9, 2024</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Siguang Peng</i></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siguang Peng</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">3</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1j9FOwjAUhp9g73DSawJdA4nsDhckxqFmEvW2sIM0rD3LaUF4JN/SbnPxRpsmTfv/3/+fCjESK7ozNTK835YFbNA2tQ4IJe6R0e0wOvL7hwziWeKH8YG1C911AHOKDEZmNlbTbRQ669l4rDJI1UTOJ2oK8iabzWGxFkmr5+T2pkIXjK5BuwqemRo2GDRf+4SNvpAje+2qXpG9IRfjxrKXv0DJVMEjnfUn8dFDUeQiGXUrESumUxNdy0tA15KwrNHGOt/Tv7ubZnfygWz2prn9nF+j3SLH91QqlcrFT+Ug/0E+cWVcHP3loBn/4wcT9K4h5htjwHAY -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea022404301ex1-1_btcdigi.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED DECEMBER 6, 2024, BETWEEN BTC DIGITAL LTD. AND AEGIS CAPITAL CORP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">December 6, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Aegis Capital Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">1345 Avenue of the Americas, 27th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">New York, NY 10105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BTC Digital Ltd., a Cayman Islands exempted company
(the &ldquo;<B><U>Company</U></B>&rdquo;), agrees, subject to the terms and conditions in this agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;),
to issue and sell to Aegis Capital Corp. (the &ldquo;<B><U>Underwriter</U></B>&rdquo;) an aggregate of 2,500,000 of the Company&rsquo;s
ordinary shares, par value $0.06 per share (&ldquo;<B><U>Ordinary Shares</U></B>&rdquo;; such Ordinary Shares, the &ldquo;<B><U>Closing
Shares</U></B>&rdquo;) and pre-funded warrants (the &ldquo;<B><U>Closing Pre-Funded Warrants</U></B>&rdquo;) each to purchase one (1)
Ordinary Share. At the option of the Underwriter, the Company agrees, subject to the terms and conditions herein, to issue and sell up
to an aggregate of 375,000 additional Ordinary Shares representing fifteen percent (15.0%) of the Closing Shares and Closing Pre-funded
Warrants sold in the offering (the &ldquo;<B><U>Option Shares</U></B>&rdquo;). The Closing Shares and the Option Shares are herein referred
to collectively as the &ldquo;<B><U>Shares</U></B>&rdquo;. The number of Shares and Closing Pre-funded Warrants to be purchased by the
Underwriter is set forth opposite its name in Schedule 4.1.2 hereto. Aegis Capital Corp. has agreed to act as the Underwriter in connection
with the offering and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Definitions</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.1.   &ldquo;<B><U>Affiliate</U></B>&rdquo;
has the meaning set forth in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.2.   &ldquo;<B><U>Applicable
Time</U></B>&rdquo; means 9:00 AM Eastern Time on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.3.   &ldquo;<B><U>Base
Prospectus</U></B>&rdquo; means the prospectus included in the Registration Statement at the time at which the Commission declared the
Registration Statement effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.4.   &ldquo;<B><U>Bona
Fide Electronic Road Show</U></B>&rdquo; means a &ldquo;bona fide electronic road show&rdquo; (as defined in Rule 433(h)(5) under the
Securities Act) that the Company has made available without restriction by &ldquo;graphic means&rdquo; (as defined in Rule 405 under the
Securities Act) to any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.5.   &ldquo;<B><U>Business
Day</U></B>&rdquo; means a day on which the Nasdaq Capital Market is open for trading and on which banks in New York are open for business
and not permitted by law or executive order to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.6.   &ldquo;<B><U>Commission</U></B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.7.   &ldquo;<B><U>Emerging
Growth Company</U></B>&rdquo; means an &ldquo;emerging growth company&rdquo; (as defined in Section 2(a) of the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.8.   &ldquo;<B><U>Exchange
Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.9.   &ldquo;<B><U>Exempt
Issuance</U></B>&rdquo; means securities issued (i) under the Company&rsquo;s current or future equity incentive plans or issued to employees,
directors or officers as compensation or consideration in the ordinary course of business, including any issuance of options (and the
underlying Ordinary Shares) in exchange for options issued under the Company&rsquo;s equity incentive plans, (ii) issued pursuant to agreements,
options, restricted share units or convertible securities existing as of the date hereof provided the terms are not modified, (iii) issued
pursuant to acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity, purchase of assets, reorganization
or otherwise) approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the Standstill Period, and provided that any such issuance shall only be to a Person (or to the equityholders
of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not
include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.10.   &ldquo;<B><U>Final
Prospectus Supplement</U></B>&rdquo; means the prospectus supplement to the Base Prospectus relating to the Securities and the Offering
in accordance with the provisions of Rule 430B and Rule 424(b) of the Securities Act Regulations, including any documents incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.11.   &ldquo;<B><U>Free
Writing Prospectus</U></B>&rdquo; has the meaning set forth in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.12.   &ldquo;<B><U>Foreign
Counsel</U></B>&rdquo; means Conyers Dill &amp; Pearman, 29th Floor, One Exchange Square, 8 Connaught Place, Central, Hong Kong.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.13.   &ldquo;<B><U>Indebtedness</U></B>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 in aggregate (other than trade accounts payable incurred
in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c)
the present value of any lease payments in excess of $50,000 in aggregate due under leases required to be capitalized in accordance with
GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.14.   &ldquo;<B><U>Investment
Company Act</U></B>&rdquo; means the Investment Company Act of 1940, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.15.   &ldquo;<B><U>Issuer
Free Writing Prospectus</U></B>&rdquo; means an &ldquo;issuer free writing prospectus&rdquo; (as defined in Rule 433(h)(1) under the Securities
Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.16.   &ldquo;<B><U>Person</U></B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.17.   &ldquo;<B><U>Preliminary
Prospectus Supplement</U></B>&rdquo; means the preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus
as so supplemented) that described the Securities and the Offering (as defined herein) and omitted the Rule 430B Information and that
was used prior to the filing of the Final Prospectus Supplement, including any documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.18.   &ldquo;<B><U>Pricing
Disclosure Package</U></B>&rdquo; means the Preliminary Prospectus Supplement and the Base Prospectus collectively with this Agreement
(including documents attached hereto or incorporated by reference herein) and the documents and pricing information set forth in Schedule
1.18 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.19.   &ldquo;<B><U>Prospectus
Delivery Period</U></B>&rdquo; means such period of time after the first date of the public offering of the Shares as in the opinion of
counsel for the Underwriter a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for
Rule 172 under the Securities Act) in connection with sales of the Shares by the Underwriter or dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.20.   &ldquo;<B><U>Registration
Statement</U></B>&rdquo; means (a) the registration statement on Form S-3 (File No. 333-283367), including a prospectus, registering the
offer and sale of the Shares and Closing Pre-Funded Warrants under the Securities Act as amended at the time the Commission declared it
effective, including each of the exhibits, financial statements and schedules thereto, (b) any Rule 430A Information, and (c) any Rule
462(b) Registration Statement, including in each case any documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.21.   &ldquo;<B><U>Rule
430A Information</U></B>&rdquo; means the information deemed, pursuant to Rule 430A under the Securities Act, to be part of the Registration
Statement at the time the Commission declared the Registration Statement effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.22.   &ldquo;<B><U>Rule
462(b) Registration Statement</U></B>&rdquo; means an abbreviated registration statement to register the offer and sale of additional
Shares pursuant to Rule 462(b) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.23.   &ldquo;<B><U>Sarbanes-Oxley
Act</U></B>&rdquo; means the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.24.   &ldquo;<B><U>Securities
Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.25.   &ldquo;<B><U>Standstill
Period</U></B>&rdquo; has the meaning set forth in Section 5.10.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.26.   &ldquo;<B><U>Testing-the-Waters
Communication</U></B>&rdquo; means any oral or Written Communication with potential investors undertaken in reliance on Section 5(d) of
the Securities Act and Rule 163B thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.27.   &ldquo;<B><U>U.S.
Company Counsel</U></B>&rdquo; means VCL Law LLP, 1945 Old Gallows Road, Suite 260, Vienna, VA 22182.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.28.   &ldquo;<B><U>Written
Communication</U></B>&rdquo; has the meaning set forth in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.29.   &ldquo;<B><U>Written
Testing-the-Waters Communications</U></B>&rdquo; means any Testing-the-Waters Communication that is a Written Communication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B><U>Representations and Warranties of the Company</U></B>. The Company hereby represents and warrants
to, and agrees with, the Underwriter that the following matters are true and accurate and do not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. Any certificate
signed by an officer of the Company and delivered to the Underwriter or to counsel for the Underwriter shall be deemed to be a representation
and warranty by the Company to the Underwriter as to the matters set forth therein.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.1.   <B><U>Registration
Statement</U>.</B> The Company has prepared and filed the Registration Statement with the Commission under the Securities Act. The Commission
has declared the Registration Statement effective under the Securities Act and the Company has not as of the date of this Agreement filed
a post-effective amendment to the Registration Statement. The Commission has not issued any order suspending the effectiveness of the
Registration Statement or any order preventing or suspending the use of the Registration Statement, the Final Prospectus Supplement, any
Preliminary Prospectus Supplement, any Issuer Free Writing Prospectus or any Testing-the-Waters Communication, and no proceedings for
such purpose or pursuant to Section 8A of the Securities Act have been initiated, are pending before or, to the Company&rsquo;s knowledge,
threatened by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.1.1.   The
Registration Statement, at the time it became effective, did not contain, and any post-effective amendment thereto, as of the effective
date of such amendment, will not contain, any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; <U>provided</U> that the Company makes no representation or warranty
with respect to any statements or omissions made in reliance upon and in conformity with information relating to the Underwriter furnished
to the Company in writing by the Underwriter expressly for use in the Registration Statement (including any post-effective amendment thereto),
the Pricing Disclosure Package, the Final Prospectus Supplement (including any amendments or supplements thereto), any Preliminary Prospectus
Supplement, any Issuer Free Writing Prospectus or any Testing-the-Waters Communication, it being understood and agreed that the only such
information furnished by the Underwriter consists of the information described in Section 9.3 hereof (collectively, the &ldquo;<B><U>Underwriter
Information</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.1.2.   Each
of the Registration Statement and any post-effective amendment thereto, at the time it became effective and at the date hereof, complied
and will comply in all material respects with the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.1.3.   The
prospectus in the form in which it was filed with the Commission in connection with the Initial Registration Statement is herein called
the &ldquo;<B><U>Base Prospectus</U></B>.&rdquo; Each preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus
as so supplemented) that described the Securities and the Offering and omitted the Rule 430B Information and that was used prior to the
filing of the final prospectus supplement referred to in the following paragraph is herein called a &ldquo;<B><U>Preliminary Prospectus</U></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.1.4.   Promptly
after the execution and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement
to the Base Prospectus relating to the Securities and the Offering in accordance with the provisions of Rule 430B and Rule 424(b) of the
Securities Act Regulations. Such final prospectus supplement (including the Base Prospectus as so supplemented), in the form filed with
the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &ldquo;<B><U>Prospectus</U></B>.&rdquo; Any reference
herein to the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.2.   <B><U>Pricing
Disclosure Package</U></B>. The Pricing Disclosure Package, as of the Applicable Time, did not, and as of the Closing Date (as defined
below) and as of any Additional Closing Date (as defined below), as the case may be, will not, contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or
omissions made in reliance upon and in conformity with the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.3.   <B><U>Final
Prospectus Supplement</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.3.1.   Each
of the Final Prospectus Supplement and any amendments or supplements thereto, as of its date, as of the time it is filed with the Commission
pursuant to Rule 424(b) under the Securities Act, as of the Closing Date and as of any Additional Closing Date, as the case may be, will
not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation
or warranty with respect to any statements or omissions made in reliance upon and in conformity with the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.3.2.   Each
of the Final Prospectus Supplement and any amendments or supplements thereto, at the time it is filed with the Commission pursuant to
Rule 424(b) under the Securities Act, as of the Closing Date and as of any Additional Closing Date, as the case may be, will comply in
all material respects with the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.4.   <B><U>Preliminary
Prospectus Supplements</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.1.   Each
Preliminary Prospectus Supplement, when considered together with any amendments or supplements thereto, as of the time it was filed with
the Commission pursuant to Rule 424(a) under the Securities Act, if any, did not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made
in reliance upon and in conformity with the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.2.   Each
Preliminary Prospectus Supplement, when considered together with any amendments or supplements thereto, at the time it was filed with
the Commission pursuant to Rule 424(a) under the Securities Act, if any, complied in all material respects with the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.5.   <B><U>Issuer
Free Writing Prospectuses</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.1.   Each
Issuer Free Writing Prospectus, when considered together with the Preliminary Prospectus Supplement accompanying, or delivered prior to
the delivery of, such Issuer Free Writing Prospectus, did not, as of the date of such Issuer Free Writing Prospectus, and will not, as
of the Closing Date and as of any Additional Closing Date, as the case may be, contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made
in reliance upon and in conformity with the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.2.   Each
Issuer Free Writing Prospectus, at the time of filing with the Commission, complied or will comply in all material respects with the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.3.   The
Company has filed, or will file, with the Commission, within the time period specified in Rule 433(d) under the Securities Act, any Free
Writing Prospectus it is required to file pursuant to Rule 433(d) under the Securities Act. The Company has made available any Bona Fide
Electronic Road Show used by it in compliance with Rule 433(d)(8)(ii) under the Securities Act such that no filing of any &ldquo;road
show&rdquo; (as defined in Rule 433(h) under the Securities Act) (&ldquo;<B><U>Road Show</U></B>&rdquo;) is required in connection with
the offering of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.4.   Except
for the Issuer Free Writing Prospectuses, if any, set forth in Schedule 2.5.4 hereto and electronic road shows, if any, each furnished
to the Underwriter before first use, the Company has not used, authorized the use of, referred to or participated in the planning for
use of, and will not, without the prior consent of the Underwriter, use, authorize the use of, refer to or participate in the planning
for use of, any Free Writing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.6. <B><U>Testing-the-Waters
Communications</U></B>. The Company has not (x) alone engaged in any Testing-the-Waters Communication other than Testing-the-Waters
Communications with the consent of the Underwriter or any underwriter that the Company has previously identified to the Underwriter
with entities that are qualified institutional buyers within the meaning of Rule 144A under the Act or institutions that are
accredited investors within the meaning of Rule 501 under the Act, and (y) authorized anyone other than the Underwriter, or any
underwriter that the Company has previously identified to the Underwriter, to engage in Testing-the-Waters Communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.7.   <B><U>No
Other Disclosure Materials</U></B>. Other than the Registration Statement, the Pricing Disclosure Package, the Final Prospectus Supplement
and the Road Show, the Company (including its agents and representatives, other than the Underwriter or any underwriter that the Company
has previously identified to the Underwriter, as to which no representation or warranty is given) has not, directly or indirectly, distributed,
prepared, used, authorized, approved or referred to, and will not distribute, prepare, use, authorize, approve or refer to, any offering
material in connection with the offering and sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.8.   <B><U>Ineligible
Issuer</U></B>. At the time of filing of the Registration Statement registering the offer and sale of the Securities, the Company was
not and is not an &ldquo;ineligible issuer&rdquo; (as defined in Rule 405 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.9.   <B><U>Emerging
Growth Company</U></B>. From the time of the initial filing of the Registration Statement with the Commission (or, if earlier, the first
date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communication)
through the date hereof, the Company has been and is an Emerging Growth Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.10.   <B><U>Smaller
Reporting Company</U></B>. From the time of initial filing of the Registration Statement with the Commission (or, if earlier, the first
date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters Communication)
through the date hereof, the Company has been and is a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2 under the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.11.   <B><U>Due
Authorization</U></B>. The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations
hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and
the consummation by it of the transactions contemplated hereby has been duly and validly taken.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.12.   <B><U>Underwriting
Agreement</U></B>. This Agreement has been duly authorized, executed and delivered by the Company and, assuming the due authorization,
execution and delivery by the other parties hereto, constitutes the legal, valid and binding obligation of the Company, enforceable against
the Company in accordance with its terms, except as (i) the enforcement may be limited by bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors generally or by general
equitable principles (whether considered in a proceeding at law or in equity) relating to enforceability and (ii) rights to indemnification
and contribution hereunder may be limited by applicable law and public policy considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.13.   <B><U>No
Material Adverse Change</U></B>. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus Supplement (in each case exclusive of any amendment or supplement thereto), since the date of the most recent financial statements
included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement:
(i) there has been no material adverse change, or any development that could result in a material adverse change, in or affecting the
condition (financial or otherwise), earnings, business, properties, management, financial position, shareholders&rsquo; equity, or results
of operations, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered
as a whole; (ii) there has been no change in the share capital (other than (A) the issuance of Shares upon the exercise or settlement
(including any &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercises or settlements) of share options, restricted share units or warrants
described as outstanding, (B) the grant of options and awards under existing equity incentive plans, or (C) the repurchase of Ordinary
Shares by the Company, which were issued pursuant to the early exercise of share options by option holders and are subject to repurchase
by the Company, in each case, as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement),
or material change in the short-term debt or long-term debt of the Company or any of its subsidiaries, considered as a whole; and (iii)
the Company and its subsidiaries, considered as a whole, have not incurred any material liability or obligation, indirect, direct or contingent
(whether or not in the ordinary course of business); nor entered into any transaction or agreement (whether or not in the ordinary course
of business) that is material to the Company and its subsidiaries, considered as a whole; and (iv) there has been no dividend or distribution
of any kind declared, set aside for payment, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries
of the Company, any of its subsidiaries on any class of share capital or repurchase or redemption by the Company or any of its subsidiaries
of any class of share capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.14.   <B><U>Organization
and Good Standing of the Company and its Subsidiaries</U></B>. The Company and each of its subsidiaries have been duly incorporated and
are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business
and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective
businesses requires such qualification, and have all power and authority (corporate and other) necessary to own, lease or hold their respective
properties and to conduct the businesses in which they are engaged as described in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus Supplement, except where the failure to be in good standing, to be so qualified or to have such power
or authority could not, individually or in the aggregate, have a material adverse effect on the condition (financial or otherwise), earnings,
business, properties, management, financial position, shareholders&rsquo; equity, or results of operations of the Company and its subsidiaries,
considered as a whole, or adversely affect the performance by the Company of its obligations under this Agreement (a &ldquo;<B><U>Material
Adverse Effect</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.15. <B><U>Capitalization</U></B>.
The capitalization of the Company is as set forth in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus Supplement under the heading &ldquo;Capitalization&rdquo;. All of the outstanding share capital of the Company has been
duly authorized and validly issued and is fully paid and non-assessable. The Securities have been duly authorized and, when issued
and paid for as contemplated herein, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not
be subject to personal liability by reason of being such holders; the Securities are not and will not be subject to the preemptive
rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action
required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. None of the
outstanding Ordinary Shares of the Company were issued in violation of any preemptive rights, rights of first refusal or other
similar rights to subscribe for or purchase securities of the Company. Except as disclosed in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus Supplement, there are no authorized or outstanding options, warrants, preemptive
rights, rights of first refusal or other rights to acquire, or instruments convertible into or exchangeable or exercisable for, any
Shares of, or other equity interest in, the Company or any of its subsidiaries. All of the outstanding shares of, or other equity
interest in, each of the Company&rsquo;s subsidiaries (i) have been duly authorized and validly issued, (ii) are fully paid and
non-assessable and (iii) are owned by the Company, directly or through the Company&rsquo;s subsidiaries, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, charge, claim or restriction on voting or transfer (collectively,
&ldquo;<B><U>Liens</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.16.   <B><U>Common
Share Incentive Plans</U></B>. With respect to the Common Share options (the &ldquo;<B><U>Share Options</U></B>&rdquo;) granted pursuant
to the Common Share-based compensation plans of the Company and its subsidiaries (the &ldquo;<B><U>Company Common Share Incentive Plans</U></B>&rdquo;),
(i) each Stock Option intended to qualify as an &ldquo;incentive stock option&rdquo; under Section 422 of the Internal Revenue Code of
1986, as amended (the &ldquo;<B><U>Code</U></B>&rdquo;), so qualifies, (ii) each grant of a Share Option was duly authorized by all necessary
corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee
thereof) and any required shareholders approval by the necessary number of votes or written consents, and the award agreement governing
such grant (if any), to the Company&rsquo;s knowledge, was duly executed and delivered by each party thereto, (iii) each such grant was
made in all material respects in accordance with the terms of the Company Common Share Incentive Plans, and (iv) each such grant was properly
accounted for in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<B><U>GAAP</U></B>&rdquo;) in the financial statements (including the related notes) of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.17. <B><U>No
Violation or Default</U></B>. Neither the Company nor any of its subsidiaries is: (i) in violation of its charter, by-laws or
similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would
constitute such a default, in the due performance or observance of any term, covenant, condition or other obligation contained in
any indenture, mortgage, deed of trust, loan agreement, contract, undertaking or other agreement or instrument to which the Company
or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or
asset of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute applicable to the Company or
any of its subsidiaries or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory
authority having jurisdiction over the Company or any of its subsidiaries, or any of their respective properties or assets, except,
in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate,
have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.18.   <B><U>No
Conflicts</U></B>. None of (i) the execution, delivery and performance of this Agreement by the Company, (ii) the issuance, sale and delivery
of the Closing Shares, the Closing Pre-funded Warrants or the Option Shares, (iii) the application of the proceeds of the offering as
described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement,
or (iv) the consummation of the transactions contemplated herein will: (x) result in any violation of the terms or provisions of the charter,
by-laws or similar organizational documents of the Company or any of its subsidiaries; (y) conflict with, result in a breach or violation
of, or require the approval of shareholders, members or partners or any approval or consent of any persons under, any of the terms or
provisions of, constitute a default under, result in the termination, modification, or acceleration of, or result in the creation or imposition
of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture,
mortgage, deed of trust, loan agreement, note agreement, contract, undertaking or other agreement, obligation, condition, covenant or
instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to
which any property, right or asset of the Company or any of its subsidiaries is subject; or (z) result in the violation of any law, statute,
judgment, order, rule, decree or regulation applicable to the Company or any of its subsidiaries of any court, arbitrator, governmental
or regulatory authority, agency or body having jurisdiction over the Company or any of its subsidiaries or any of their respective properties
or assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.19.   <B><U>No
Consents Required</U></B>. No consent, approval, authorization, order, filing, registration, license or qualification of or with any court,
arbitrator, or governmental or regulatory authority, agency, or body is required for (i) the execution, delivery and performance by the
Company of this Agreement; (ii) the issuance, sale and delivery of the Securities ; or (iii) the consummation of the transactions contemplated
herein, except for such consents, approvals, authorizations, orders, filings, registrations or qualifications as (x) have already been
obtained or made and are still in full force and effect, (y) may be required by FINRA and the Nasdaq Capital Market, and (z) may be required
under applicable state securities laws in connection with the purchase, distribution and resale of the Securities by the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.20.   <B><U>Independent
Accountants</U></B>. Audit Alliance LLP, with offices at No 10 Anson Road, #20-16, International Plaza, Singapore 079903, which expressed
its opinion with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) and supporting
schedules included in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement, is an independent
registered public accounting firm with respect to the Company and its subsidiaries within the meaning of the rules and regulations of
the Commission and the Public Company Accounting Oversight Board and as required by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.21. <B><U>Financial
Statements and Other Financial Data</U></B>. The financial statements (including the related notes thereto), together with the
supporting schedules, included in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement
comply in all material respects with the applicable requirements of the Securities Act and present fairly the consolidated financial
position of the entities to which they relate as of and at the dates indicated and the results of their operations and cash flows
for the periods specified. Such financial statements, notes and schedules have been prepared in conformity with GAAP applied on a
consistent basis throughout the periods involved, except as may be expressly stated in the notes thereto and except, in the case of
unaudited interim financial statements, subject to normal year end audit adjustments and the exclusion of certain footnotes as
permitted by the applicable rules of the Commission. The financial data set forth in the Registration Statement, the Pricing
Disclosure Package and the Final Prospectus Supplement under the captions &ldquo;Capitalization&rdquo; present fairly the
information set forth therein on a basis consistent with that of the audited financial statements included in the Registration
Statement, the Pricing Disclosure Package and the Final Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.22.   <B><U>Statistical
and Market-Related Data</U></B>. The statistical and market-related data included in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus Supplement are based on or derived from sources that the Company reasonably and in good faith believes
to be accurate and reliable in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.23.   <B><U>Forward-Looking
Statements</U></B>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) included in the Registration Statement, the Pricing Disclosure Package or the Final Prospectus Supplement has been made or reaffirmed
without a reasonable basis or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.24.   <B><U>Legal
Proceedings</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement,
(i) there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings
(collectively, &ldquo;<B><U>Actions</U></B>&rdquo;) pending to which the Company or any of its subsidiaries is or may be a party or to
which any property, right or asset of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate,
if determined adversely to the Company or any of its subsidiaries, could have a Material Adverse Effect; and (ii) to the knowledge of
the Company, no such Actions are threatened or contemplated by any governmental or regulatory authority or by others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.25.   <B><U>Labor
Disputes</U></B>. No labor disturbance by or dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge
of the Company, is threatened or contemplated that could, individually or in the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.26. <B><U>Intellectual
Property Rights</U></B>. (i) The Company and its subsidiaries own or have the right to use all patents, patent applications,
trademarks, service marks, trade names, and other source indicators and registrations and applications for registration thereof,
domain name registrations, copyrights and registrations and applications for registration thereof, technology and know-how, trade
secrets, and all other intellectual property and related proprietary rights (collectively, &ldquo;<B><U>Intellectual Property
Rights</U></B>&rdquo;) necessary to conduct their respective businesses; (ii) other than as disclosed in the Prospectus Supplement,
neither the Company nor any of its subsidiaries has received any notice of infringement, misappropriation or other conflict with
(and neither the Company nor any of its subsidiaries is otherwise aware of any infringement, misappropriation or other conflict
with) the Intellectual Property Rights of any other person, except for such infringement, misappropriation or other conflict as
could not have a Material Adverse Effect; and (iii) to the knowledge of the Company, the Intellectual Property Rights of the Company
and its subsidiaries are not being infringed, misappropriated or otherwise violated by any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.27.   <B><U>Licenses
and Permits</U></B>. (i) The Company and its subsidiaries possess such valid and current certificates, authorizations, approvals, licenses
and permits (collectively, &ldquo;<B><U>Authorizations</U></B>&rdquo;) issued by, and have made all declarations, amendments, supplements
and filings with, the appropriate state, federal or foreign regulatory agencies or bodies necessary to own, lease and operate their respective
properties and to conduct their respective businesses as set forth in the Registration Statement, the Pricing Disclosure Package and the
Final Prospectus Supplement; (ii) all such Authorizations are valid and in full force and effect and the Company and its subsidiaries
are in compliance with the terms and conditions of all such Authorizations; and (iii) neither the Company nor any of its subsidiaries
has received notice of any revocation, termination or modification of, or non-compliance with, any such Authorization or has any reason
to believe that any such Authorization will not be renewed in the ordinary course, except where, in the case of clauses (i), (ii) and
(iii), the failure to possess, make or obtain such Authorizations (by possession, declaration or filing) could not, individually or in
the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.28.   <B><U>Title
to Property</U></B>. The Company and its subsidiaries have good and marketable title to, or have valid and enforceable rights to lease
or otherwise use, all items of real property and personal property (other than with respect to Intellectual Property Rights, which is
addressed exclusively in Section 2.26) that are material to the respective businesses of the Company and its subsidiaries, in each case,
free and clear of all liens, encumbrances, claims, and defects and imperfections of title, except such liens, encumbrances, claims, defects
and imperfections as (i) are disclosed in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement,
or (ii) do not materially affect the value of such property and do not materially interfere with the use made or proposed to be made of
such property by the Company and its subsidiaries. The Company and its subsidiaries have good and marketable title to, or have valid and
enforceable rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of
the Company and its subsidiaries, in each case, free and clear of all liens, encumbrances, claims and defects and imperfections of title,
except such liens, encumbrances, claims, defects and imperfections as (i) are disclosed in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus Supplement, or (ii) do not materially affect the value of such property and do not materially interfere
with the use made or proposed to be made of such property by the Company and its subsidiaries. All items of real and personal property
held under lease by the Company and its subsidiaries are held under valid, subsisting and enforceable leases, with such exceptions as
do not materially interfere with the use made or proposed to be made of such property by the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.29.   <B><U>Taxes</U></B>.
The Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the
date hereof or have timely requested extensions thereof and have paid all taxes required to be paid thereon (except as currently being
contested in good faith and for which reserves required by GAAP have been created in the financial statements of the Company). The charges,
accruals and reserves in respect of any income and other tax liability in the financial statements of the Company referred to in Section
2.21 are adequate, in accordance with GAAP principles, to meet any assessments for any taxes of the Company accruing through the end of
the last period specified in such financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.30.   <B><U>Solvency</U></B>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Closing Shares and the Closing Pre-funded Warrants hereunder, (i) the fair saleable value of the
Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and
other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably
small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital
availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or
in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The
Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under
the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The Registration Statement sets forth
as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or
any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.31.   <B><U>Investment
Company Act</U></B>. Neither the Company nor any of its subsidiaries is or, after giving effect to the offer and sale of the Securities
and the application of the proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing
Disclosure Package and the Final Prospectus Supplement, will be required to register as an &ldquo;investment company&rdquo; (as defined
in the Investment Company Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.32. <B><U>Insurance</U></B>.
The Company and its subsidiaries are insured by recognized, financially sound institutions in such amounts, with such amounts, with
such deductibles and covering such losses and risks as the Company reasonably believes to be adequate for the conduct of their
respective businesses and the value of their respective properties and as is prudent and customary for companies engaged in similar
businesses in similar industries. All insurance policies and fidelity or surety bonds insuring the Company and its subsidiaries or
their respective businesses, assets, employees, officers and directors are in full force and effect; the Company and its
subsidiaries are in compliance with the terms of such policies in all material respects; neither the Company nor any of its
subsidiaries has received notice from any insurer or agent of such insurer that capital improvements or other expenditures are
required to be made in order to continue such insurance; and neither the Company nor any of its subsidiaries has been refused any
insurance coverage sought or applied for. There are no claims by the Company or any of its subsidiaries under any such policy as to
which any insurer is denying liability or defending under a reservation of rights clause; and neither the Company nor any of its
subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that could not
have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.33.   <B><U>No
Stabilization or Manipulation</U></B>. None of the Company, nor its Affiliates, or, to the knowledge of the Company, any person acting
on its or any of their behalf (other than the Underwriter, as to which no representation or warranty is given) has taken, directly or
indirectly, any action designed to or that has constituted or that could reasonably be expected to cause or result in the stabilization
or manipulation of the price of any securities of the Company. The Company acknowledges that the Underwriter may engage in passive market
making transactions in the Ordinary Shares on the Nasdaq Capital Market (the &ldquo;<B><U>Exchange</U></B>&rdquo;) in accordance with
Regulation M under the Exchange Act (&ldquo;<B><U>Regulation M</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.34.   <B><U>Compliance
with the Sarbanes-Oxley Act</U></B>. The Company and, to the knowledge of the Company, its officers and directors, in their capacities
as such, are and have been in compliance with all applicable provisions of the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.35. <B><U>Accounting
Controls</U></B>. The Company and its subsidiaries maintain systems of &ldquo;internal control over financial reporting&rdquo; (as
defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or
under the supervision of, their principal executive and principal financial officers, or persons performing similar functions, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific
authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP
and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general or
specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. Other than as disclosed in the Registration Statement, the Company
maintains a system of internal control over financial reporting and the Company is not aware of any other material weaknesses in its
internal control over financial reporting (whether or not remediated). Other than as disclosed in the Registration Statement, since
the date of the most recent balance sheet included in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus Supplement, (x) the Company&rsquo;s auditors and the board of directors of the Company have not been advised of (A) any
new significant deficiencies or material weaknesses in the design or operation of the internal control over financial reporting of
the Company and its subsidiaries which could adversely affect the Company&rsquo;s ability to record, process, summarize, and report
financial data; or (B) any fraud, whether or not material, that involves management or other employees who have a role in the
internal control over financial reporting of the Company or its subsidiaries; and (y) there have been no significant changes in the
internal control over financial reporting of the Company or its subsidiaries or in other factors that could significantly affect,
such internal control over financial reporting, including any corrective actions with regard to significant deficiencies or material
weaknesses, since the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.36.   <B><U>Disclosure
Controls and Procedures</U></B>. The Company and its subsidiaries have established and maintain disclosure controls and procedures (as
such term is defined in Rule 13a-15(e) under the Exchange Act) that are designed to comply with the requirements of the Exchange Act;
such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company and its subsidiaries
in the reports they file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified
in the Commission&rsquo;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and
communicated to the Company&rsquo;s management as appropriate to allow timely decisions regarding required disclosure; and such disclosure
controls and procedures are effective to perform the functions for which they were established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.37. <B><U>Compliance
with Environmental Laws</U></B>. The Company and each of its subsidiaries (i) are, and at all times prior hereto were, in compliance
with all Environmental Laws (as defined below) applicable to such entity, which compliance includes, without limitation, obtaining,
maintaining and complying with all permits and authorizations and approvals required by Environmental Laws to conduct their
respective businesses; and (ii) have not received notice or otherwise have knowledge of any actual or alleged violation of
Environmental Laws, or of any actual or potential liability for or other obligation concerning the presence, disposal or release of
hazardous or toxic substances or wastes, pollutants or contaminants, and, except as described in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus Supplement, (x) there are no proceedings that are pending, or known to be
contemplated, against the Company or any of its subsidiaries under Environmental Laws, other than such proceedings regarding which
would not, individually or in the aggregate, have a Material Adverse Effect; (y) to the knowledge of the Company, none of the
Company or any of its subsidiaries is aware of any issues regarding compliance with Environmental Laws, including any pending or
proposed Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic
substances or wastes, pollutants or contaminants, that could reasonably be expected to have a material effect on the capital
expenditures, earnings or competitive position of the Company and its subsidiaries; and (z) none of the Company or any of its
subsidiaries anticipates material capital expenditures relating to Environmental Laws. As used herein, the term
&ldquo;<B><U>Environmental Laws</U></B>&rdquo; means any laws, regulations, ordinances, rules, orders, judgments, decrees, permits
or other legal requirements of any governmental authority, including, without limitation, any international, foreign, national,
state, provincial, regional, or local authority, relating to pollution, the protection of human health or safety, the environment,
or natural resources, or to the use, handling, storage, manufacturing, transportation, treatment, discharge, disposal or release of
hazardous or toxic substances or wastes, pollutants or contaminants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.38.   <B><U>Related
Party Transactions</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus
Supplement, no relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and
the directors, officers, shareholders, other Affiliates, customers or suppliers of the Company or any of its subsidiaries, on the other
hand, that would be required by the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package and the
Final Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.39.   <B><U>No
Unlawful Contributions or Other Payments</U></B>. Neither the Company nor any of its subsidiaries, nor any director, officer of the Company,
nor, to the knowledge of the Company, any agent, employee, Affiliate or other person associated with or acting on behalf of the Company
or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government or regulatory
official or employee; (iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; or (iv) violated or
is in violation of any provision of (y) the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder
(the &ldquo;<B><U>FCPA</U></B>&rdquo;), or (z) any non-U.S. anti-bribery or anti-corruption statute or regulation. The Company and its
subsidiaries have instituted and maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable
anti-bribery and anti-corruption laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.40.   <B><U>Compliance
with Anti-Money Laundering Laws</U></B>. The operations of the Company and its subsidiaries are and have been conducted at all times in
compliance with all applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the applicable anti-money laundering statutes of all jurisdictions where the Company or any of its
subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental agency (collectively, the &ldquo;<B><U>Anti-Money Laundering Laws</U></B>&rdquo;); and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.41. <B><U>Compliance
with OFAC</U></B>. Neither the Company nor any of its subsidiaries nor any director, officer of the Company, nor, to the knowledge
of the Company, any agent, employee or Affiliate of the Company or any of its subsidiaries is an individual or entity (an
&ldquo;<B><U>OFAC Person</U></B>&rdquo;), or is owned or controlled by an OFAC Person, that is currently the subject or target of
any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control
of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;) or the U.S. Department of State and including, without
limitation, the designation as a &ldquo;specially designated national&rdquo; or &ldquo;blocked person&rdquo;), the United Nations
Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively,
&ldquo;<B><U>Sanctions</U></B>&rdquo;), nor is the Company or any of its subsidiaries located, organized or resident in a country or
territory that is the subject or the target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea, Sudan and
Syria (each, a &ldquo;<B><U>Sanctioned Country</U></B>&rdquo;); and the Company will not directly or indirectly use the proceeds of
the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other OFAC
Person (i) to fund or facilitate any activities of or business with any OFAC Person that, at the time of such funding or
facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities or business in any Sanctioned
Country or (iii) in any other manner that will result in a violation by any OFAC Person (including any OFAC Person participating in
the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. Since the Company&rsquo;s inception, the
Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with
any OFAC Person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any
Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.42.   <B><U>No
Registration Rights</U></B>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus
Supplement, there are no contracts, agreements or understandings between the Company or any of its subsidiaries, on the one hand, and
any person, on the other hand, granting such person any rights to require the Company or any of its subsidiaries to file a registration
statement under the Securities Act with respect to any securities of the Company or any of its subsidiaries owned or to be owned by such
person or to require the Company or any of its subsidiaries to include such securities in any securities to be registered pursuant to
any registration statement to be filed by the Company or any of its subsidiaries under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.43.   <B><U>Subsidiaries</U></B>.
The subsidiaries of the Company shall be referred to hereinafter each as a &ldquo;<B><U>Subsidiary</U></B>&rdquo; and collectively as
&ldquo;<B><U>Subsidiaries</U></B>.&rdquo; The Subsidiaries of the Company listed in Schedule 2.43 hereto are the only &ldquo;significant
subsidiaries&rdquo; (as defined under Rule 1.02(w) of Regulation S-X under the Securities Act) of the Company (the &ldquo;<B><U>Significant
Subsidiaries</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.44.   <B><U>No
Restrictions on Subsidiaries</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus Supplement, no Subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the
Company, from making any other distribution on such Subsidiary&rsquo;s share capital or similar ownership interest, from repaying to the
Company any loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary&rsquo;s properties or assets
to the Company or any other Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.45.   <B><U>Exchange
Listing</U></B>. The Ordinary Shares are listed on the Exchange, and the Company has taken no action designed to, or likely to have the
effect of, delisting the Ordinary Shares from the Exchange, nor has the Company received any notification that the Exchange is contemplating
terminating such listing, except as described in the Registration Statement, the Disclosure Package and the Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.46. <B><U>Exchange
Act Registration</U></B>. The Ordinary Shares are registered pursuant to Section 12(b) under the Exchange Act. The Company has taken
no action designed to, or likely to have the effect of, terminating the registration of the Ordinary Shares under the Exchange Act,
nor has the Company received any notification that the Commission is contemplating terminating such registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.47.   <B><U>Prior
Securities Transactions</U></B>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Disclosure Package and the Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.48.   <B><U>Application
of Takeover Protections</U></B>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable as a result of the Underwriter and the Company fulfilling their obligations or exercising
their rights hereunder (including documents incorporated herein by reference or attached hereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.49.   <B><U>D&amp;O
Questionnaires</U></B>. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;<B><U>Questionnaires</U></B>&rdquo;)
completed by each of the Company&rsquo;s directors, officers and beneficial holders of 5% or more of the Company&rsquo;s Ordinary Shares
immediately prior to the Offering as supplemented by all information concerning the Company&rsquo;s directors, officers and principal
shareholders as described in the Registration Statement, the Disclosure Package and the Prospectus Supplement, provided to the Underwriter
is true and correct in all material respects and the Company has not become aware of any information which would cause the information
disclosed in the Questionnaires to become inaccurate and incorrect in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.50.   <B><U>No
Integrated Offering</U></B>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
this offering of the Closing Shares and the Closing Pre-funded Warrants to be integrated with prior offerings by the Company for purposes
of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.51.   <B><U>Litigation;
Governmental Proceedings</U></B>. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental
proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company, any of its Subsidiaries or, to
the Company&rsquo;s knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Disclosure
Package and the Prospectus Supplement which is required to be disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.52.   <B><U>FINRA
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.52.1. <B><U>No
Broker&rsquo;s Fees</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus Supplement, neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with
any person (other than this Agreement) that would give rise to a valid claim against any of them or the Underwriter for a brokerage
commission, finder&rsquo;s fee or like payment in connection with the offering and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.52.2.   <B><U>Payments
Within Six (6) Months</U></B>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus Supplement,
the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee,
consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who
raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the six (6) months prior to the initial filing of the Registration Statement, other than
the payment to the Underwriter as provided hereunder in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.52.3.   <B><U>Use
of Proceeds</U></B>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates,
except as specifically authorized herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.52.4.   <B><U>FINRA
Affiliation</U></B>. There is no (i) officer or director of the Company, (ii) to the Company&rsquo;s knowledge, any beneficial owner of
10% or more of any class of the Company&rsquo;s securities or (iii) to the Company&rsquo;s knowledge, any beneficial owner of the Company&rsquo;s
unregistered equity securities which were acquired during the 180-day period immediately preceding the filing of the Registration Statement
that is an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules
and regulations of FINRA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.52.5.   <B><U>Information</U></B>.
All information provided by the Company in any FINRA questionnaire to Underwriter&rsquo;s Counsel specifically for use by Underwriter&rsquo;s
Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all
material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Representations and Warranties of the Underwriter</U></B>. The Underwriter represents and warrants
to, and agrees with, the Company:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.1.   <B><U>No
Testing-the-Waters Communications</U></B>. The Underwriter has not (i) alone engaged in any Testing-the-Waters Communication and (ii)
authorized anyone to engage in Testing-the-Waters Communications. The Underwriter has not distributed, or authorized anyone else to distribute,
any Written Testing-the-Waters Communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Purchase and Resale</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.1.   <B><U>Agreements
to Sell and Purchase</U></B>. On the basis of the representations, warranties and covenants herein and subject to the conditions herein
and any adjustments made in accordance with Section 4.3 hereof,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.1.1.   The
Company agrees to issue and sell the Closing Shares and Closing Pre-Funded Warrants to the Underwriter; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.1.2.   The
Underwriter agrees to purchase from the Company the number of Closing Shares and Closing Pre-Funded Warrants set forth opposite the Underwriter&rsquo;s
name in Schedule 4.1.2 hereto, subject to such adjustments as the Underwriter in its sole discretion shall make to eliminate any sales
or purchases of fractional Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.1.3.   The
Closing Shares are to be offered initially to the public at the offering price set forth on the cover page of the Final Prospectus Supplement
(the &ldquo;<B><U>Public Offering Price</U></B>&rdquo;). The purchase price per Closing Share to be paid by the Underwriter to the Company
shall be $7.44 per Closing Share and the purchase price per Closing Pre-funded Warrant shall be the purchase price per Closing Share less
the exercise price of $0.001 (the &ldquo;<B><U>Purchase Price</U></B>&rdquo;), which represents the Public Offering Price less an underwriting
discount of 7.0%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.1.4.   Payment
for the Closing Shares and Closing Pre-Funded Warrants (the &ldquo;<B><U>Closing Payment</U></B>&rdquo;) shall be made by wire transfer
in immediately available funds to the accounts specified by the Company to the Underwriter at the offices of Kaufman &amp; Canoles, P.C.
at 10:00 a.m., ET, on December 9, 2024 or at such other place on the same or such other date and time, not later than the fifth (5th)
Business Day thereafter, as the Underwriter and the Company may agree upon in writing (the &ldquo;<B><U>Closing Date</U></B>&rdquo;).
The Closing Payment shall be made against delivery of the Closing Shares and Closing Pre-Funded Warrants to be purchased on the Closing
Date to the Underwriter with any transfer taxes, stamp duties and other similar taxes payable in connection with the sale of the Closing
Shares and the Closing Pre-funded Warrants duly paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.2.   <B><U>Over-Allotment
Option</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.2.1.   On
the basis of the representations, warranties and covenants herein and subject to the conditions herein, the Underwriter shall have the
option to purchase the Option Shares from the Company (the &ldquo;<B><U>Over-Allotment Option</U></B>&rdquo;), in each case, at a price
per Share equal to the Purchase Price less an amount per Closing Share equal to any dividends or distributions declared by the Company
and payable on the Closing Shares but not payable on the Option Shares (the &ldquo;<B><U>Over-Allotment Option Purchase Price</U></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.2.2.   Upon
an exercise of the Over-Allotment Option and subject to the terms and conditions herein, the Company agrees to issue and sell the Option
Shares to the Underwriter;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.2.3.   The
Underwriter may exercise the Over-Allotment Option at any time in whole, or from time to time in part, on or before the forty-fifth (45th)
day following the date of the Final Prospectus Supplement, by written notice from the Underwriter to the Company (the &ldquo;<B><U>Over-Allotment
Exercise Notice</U></B>&rdquo;). The Underwriter must give the Over-Allotment Exercise Notice to the Company at least two (2) Business
Days prior to the Closing Date or the applicable Additional Closing Date, as the case may be. The Underwriter may cancel any exercise
of the Over-Allotment Option at any time prior to the Closing Date or the applicable Additional Closing Date, as the case may be, by giving
written notice of such cancellation to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.2.4.   The
Over-Allotment Exercise Notice shall set forth each of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">4.2.4.1   the
aggregate number of Option Shares as to which the Over-Allotment Option is being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">4.2.4.2   the
Over-Allotment Option Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">4.2.4.3   the
names and denominations in which the Option Shares are to be registered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">4.2.4.4   the
applicable Additional Closing Date, which may be the same date and time as the Closing Date but shall not be earlier than the Closing
Date nor later than the tenth (10th) full Business Day after the date of the Over-Allotment Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.2.5.   Payment
for the Option Shares (the &ldquo;<B><U>Option Shares Payment</U></B>&rdquo;) shall be made by wire transfer in immediately available
funds to the accounts specified by the Company to the Underwriter at the offices of Kaufman &amp; Canoles, P.C. at 10:00 a.m. ET on the
date specified in the corresponding Over-Allotment Exercise Notice, or at such other place on the same or such other date and time, not
later than the fifth Business Day thereafter, as the Underwriter and the Company may agree upon in writing (an &ldquo;<B><U>Additional
Closing Date</U></B>&rdquo;). The Option Shares Payment shall be made against delivery to the Underwriter for the respective accounts
of the Underwriter of the Option Shares to be purchased on any Additional Closing Date, with any transfer taxes, stamp duties and other
similar taxes payable in connection with the sale of the Option Shares duly paid by the Company. Delivery of the Option Shares shall be
made through the facilities of DTC unless the Underwriter shall otherwise instruct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.3.   <B><U>Public
Offering</U></B>. The Company understands that the Underwriter intends to make a public offering of the Shares as soon after the effectiveness
of this Agreement as in the judgment of the Underwriter is advisable, and initially to offer the Shares on the terms set forth in the
Final Prospectus Supplement. The Company acknowledges and agrees that the Underwriter may offer and sell Shares to or through any Affiliate
of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B><U>Covenants of the Company</U></B>. The Company hereby covenants and agrees with the Underwriter as
follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.1.   <B><U>Filings
with the Commission</U></B>. The Company will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.1.1.   prepare
and file the Final Prospectus Supplement (in a form approved by the Underwriter and containing the Rule 430A Information) with the Commission
in accordance with and within the time periods specified by Rules 424(b) and 430A under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.1.2.   file
any Issuer Free Writing Prospectus with the Commission to the extent required by Rule 433 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.1.3.   file
with the Commission such reports as may be required by Rule 463 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.2.   <B><U>Notice
to the Underwriter</U></B>. The Company will advise the Underwriter promptly, and confirm such advice in writing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.1.   when
the Registration Statement has become effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.2.   when
the Final Prospectus Supplement has been filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.3.   when
any amendment to the Registration Statement has been filed or becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.4.   when
any Rule 462(b) Registration Statement has been filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.5.   when
any supplement to the Final Prospectus Supplement, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication or
any amendment to the Final Prospectus Supplement has been filed or distributed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.6.   of
(x) any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Final Prospectus
Supplement, (y) the receipt of any comments from the Commission relating to the Registration Statement or (z) any other request by the
Commission for any additional information, including, but not limited to, any request for information concerning any Testing-the-Waters
Communication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.7.   of
(x) the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of the Registration Statement, the Pricing Disclosure Package, the Final Prospectus Supplement, any Preliminary Prospectus Supplement,
any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication or (y) the initiation or, to the knowledge of the Company,
threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.8.   of
the occurrence of any event or development within the Prospectus Delivery Period as a result of which, the Final Prospectus Supplement,
the Pricing Disclosure Package, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication as then amended or
supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances existing when the Final Prospectus Supplement, the Pricing Disclosure Package, any such Issuer
Free Writing Prospectus or any such Written Testing-the-Waters Communication is delivered to a purchaser, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.9. of the
issuance by any governmental or regulatory authority or any order preventing or suspending the use of any of the Registration
Statement, the Pricing Disclosure Package, the Final Prospectus Supplement, any Preliminary Prospectus Supplement, any Issuer Free
Writing Prospectus or any Testing-the-Waters Communication or the initiation or threatening for that purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.2.10.   of
the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction
or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.3.   <B><U>Ongoing
Compliance</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.1.   If
during the Prospectus Delivery Period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">5.3.1.1   any
event or development shall occur or condition shall exist as a result of which the Final Prospectus Supplement as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances existing when the Final Prospectus Supplement is delivered to a purchaser, not misleading, the Company
will, as soon as reasonably possible, notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with
the Commission and furnish, at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments
or supplements to the Final Prospectus Supplement as may be necessary so that the statements in the Final Prospectus Supplement as so
amended or supplemented will not, in the light of the circumstances existing when the Final Prospectus Supplement is delivered to a purchaser,
be misleading; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">5.3.1.2   it
is necessary to amend or supplement the Final Prospectus Supplement to comply with applicable law, the Company will, as soon as reasonably
possible, notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission and furnish,
at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Final
Prospectus Supplement as may be necessary so that the Final Prospectus Supplement will comply with applicable law; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.3.2.   if
at any time prior to the Closing Date or any Additional Closing Date, as the case may be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">5.3.2.1 any
event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or
supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not
misleading, the Company will immediately notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof,
file with the Commission (to the extent required) and furnish, at its own expense, to the Underwriter and to such dealers as the
Underwriter may designate such amendments or supplements to the Pricing Disclosure Package as may be necessary so that the
statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when
the Pricing Disclosure Package is delivered to a purchaser, be misleading; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">5.3.2.2   it
is necessary to amend or supplement the Pricing Disclosure Package to comply with applicable law, the Company will immediately notify
the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission (to the extent required) and
furnish, at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to
the Pricing Disclosure Package as may be necessary so that the Pricing Disclosure Package will comply with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.4.   <B><U>Amendments,
Supplements and Issuer Free Writing Prospectuses</U></B>. Before (i) using, authorizing, approving, referring to, distributing or filing
any Issuer Free Writing Prospectus, (ii) filing (x) any Rule 462(b) Registration Statement or (y) any amendment or supplement to the Registration
Statement or the Final Prospectus Supplement, or (iii) distributing any amendment or supplement to the Pricing Disclosure Package or the
Final Prospectus Supplement, the Company will furnish to the Underwriter and counsel for the Underwriter a copy of the proposed Issuer
Free Writing Prospectus, Rule 462(b) Registration Statement or other amendment or supplement for review and will not use, authorize, refer
to, distribute or file any such Issuer Free Writing Prospectus or Rule 462(b) Registration Statement, or file or distribute any such proposed
amendment or supplement (A) to which the Underwriter objects in a timely manner and (B) which is not in compliance with the Securities
Act. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus
that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.5.   <B><U>Delivery
of Copies</U></B>. The Company will, upon request of the Underwriter, deliver, without charge, (i) to the Underwriter, three signed copies
of the Registration Statement as originally filed and each amendment thereto, in each case, including all exhibits and consents filed
therewith; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and each amendment thereto
(without exhibits and consents) and (B) during the Prospectus Delivery Period, as many copies of the Final Prospectus Supplement (including
all amendments and supplements thereto and each Issuer Free Writing Prospectus) as the Underwriter may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.6.   <B><U>Emerging
Growth Company Status</U></B>. The Company will promptly notify the Underwriter if the Company ceases to be an Emerging Growth Company
at any time prior to the later of (i) completion of the distribution of the Shares within the meaning of the Securities Act and (ii) completion
of the Standstill Period (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.7. <B><U>Blue
Sky Compliance</U></B>. The Company will use its best efforts, with the Underwriter&rsquo;s cooperation, if necessary, to qualify or
register (or to obtain exemptions from qualifying or registering) the Shares for offer and sale under the securities or Blue Sky
laws of such jurisdictions as the Underwriter shall reasonably request and will use its reasonable best efforts, with the
Underwriter&rsquo;s cooperation, if necessary, to continue such qualifications, registrations and exemptions in effect so long as
required for the distribution of the Shares; <U>provided </U>that the Company shall not be required to (i) qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so
qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any
such jurisdiction if it is not otherwise so subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.8.   <B><U>Earning
Statement</U></B>. The Company will make generally available to its security holders and the Underwriter as soon as practicable an earning
statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 under the Securities Act covering a period
of at least 12 months beginning after the &ldquo;effective date&rdquo; (as defined in Rule 158 under the Securities Act) of the Registration
Statement; <U>provided</U> that the Company will be deemed to have furnished such statement to its security holders and the Underwriter
to the extent it is filed on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system (&ldquo;<B><U>EDGAR</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.9.   <B><U>Use
of Proceeds</U></B>. The Company shall apply the net proceeds from the sale of the Closing Shares, the Closing Pre-funded Warrants and
the Option Shares in the manner described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.10.   <B><U>Clear
Market</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.10.1.   For
a period of ninety (90) days after the Closing Date (the &ldquo;<B><U>Standstill Period</U></B>&rdquo;), the Company will not (x) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file with the Commission a registration statement
under the Securities Act relating to, any Ordinary Shares or any securities convertible into or exercisable or exchangeable for Ordinary
Shares, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (y) enter into any swap or other
agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Ordinary Shares or any such other
securities, whether any such transaction described in clause (x) or (y) above is to be settled by delivery of Ordinary Shares or such
other securities, in cash or otherwise, without the prior written consent of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.10.2. The
restrictions contained in Section 5.10.1 hereof shall not apply to: (A) the Shares, (B) any Ordinary Shares issued under Company
Share Incentive Plans or warrants issued by the Company, in each case, described as outstanding in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus Supplement, (C) any options and other awards granted under a Company Common
Share Incentive Plan as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus Supplement,
provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit any registration statement in connection therewith to be filed publicly or declared effective during
the Standstill Period (D) the amendment of a Company Common Share Incentive Plan as described in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus Supplement, (E) the filing by the Company of any registration statement on Form
S-8 or a successor form thereto relating to a Company Common Share Incentive Plan described in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus Supplement and (F) Ordinary Shares or other securities issued pursuant to
acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity, purchase of assets, reorganization or
otherwise) approved by a majority of the disinterested directors of the Company, provided that such securities are issued as
&ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of
any registration statement in connection therewith during the Standstill Period, and provided that any such issuance shall only be
to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of
an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition
to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose
of raising capital or to an entity whose primary business is investing in securities; <U>provided</U>, <U>however</U>, that any such
Ordinary Shares or other securities issued or granted pursuant to clauses (B), (C) and (F) during the Standstill Period shall not be
saleable in the public market until the expiration of the Standstill Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.10.3.   If
the Underwriter, in its sole discretion, agrees to release or waive the restrictions set forth in any Lock-Up Agreement as described in
Section 8.9 and provides the Company with notice of the impending release or waiver substantially in the form of <B><U>Exhibit 5.10.3.1</U></B>
hereto at least three (3) Business Days before the effective date of the release or waiver, then the Company agrees to announce the impending
release or waiver by a press release substantially in the form of <B><U>Exhibit 5.10.3.2</U></B> hereto through a major news service at
least two (2) Business Days before the effective date of the release or waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.10.4.   Notwithstanding
the foregoing, this Section 5.10 shall not apply to an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.11.   <B><U>No
Stabilization or Manipulation</U></B>. None of the Company, its Affiliates or any person acting on its or any of their behalf (other than
the Underwriter, as to which no covenant is given) will take, directly or indirectly, any action designed to or that constitutes or that
could reasonably be expected to cause or result in the stabilization or manipulation of the price of any securities of the Company. The
Company acknowledges that the Underwriter may engage in passive market making transactions in the Ordinary Shares on the Exchange in accordance
with Regulation M.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.12.   <B><U>Investment
Company Act</U></B>. The Company shall not invest, or otherwise use the proceeds received by the Company from the sale of the Closing
Shares, the Closing Pre-funded Warrants or the Option Shares in such a manner as would require the Company or any of its subsidiaries
to register as an &ldquo;investment company&rdquo; (as defined in the Investment Company Act) under the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.13.   <B><U>Transfer
Agent</U></B>. For the period of two years from the date of this Agreement, the Company shall engage and maintain, at its expense, a registrar
and transfer agent for the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.14.   <B><U>Reports</U></B>.
For the period of two years from the date of this Agreement, the Company will furnish to the Underwriter, as soon as they are available,
copies of all reports or other communications (financial or other) furnished to holders of the Ordinary Shares, and copies of any reports
and financial statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system;
<U>provided</U> that the Company will be deemed to have furnished such reports and financial statements to the Underwriter to the extent
they are filed on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.15.   <B><U>Right
of First Refusal</U></B>. The Company agrees that, if, for the period ending twelve (12) months after the Closing Date, the Company or
any of its subsidiaries: (a) decides to finance or refinance any indebtedness, the Underwriter (or any affiliate designated by the Underwriter)
shall have the right to act as sole book-runner, sole manager, sole placement agent or sole agent with respect to such financing or refinancing;
or (b) decides to raise funds by means of a public offering (including at-the-market facility) or a private placement or any other capital
raising financing of equity, equity-linked or debt securities, the Underwriter (or any affiliate designated by the Underwriter) shall
have the right to act as sole book-running manager, sole underwriter or sole placement agent for such financing. If the Underwriter or
one of its affiliates decides to accept any such engagement, the agreement governing such engagement (each, a &ldquo;<B><U>Subsequent
Transaction Agreement</U></B>&rdquo;) will contain, among other things, provisions for customary fees for transactions of similar size
and nature, but in no event will the fees be less than those outlined herein, and the provisions of this Agreement, including indemnification,
that are appropriate to such a transaction. Notwithstanding the foregoing, the decision to accept the Company&rsquo;s engagement under
this Section 5.15 shall be made by the Underwriter or one of its affiliates, by a written notice to the Company, within ten (10) days
of the receipt of the Company&rsquo;s notification of its financing needs, including a detailed term sheet. The Underwriter&rsquo;s determination
of whether in any case to exercise its right of first refusal will be strictly limited to the terms on such term sheet, and any waiver
of such right of first refusal shall apply only to such specific terms. If the Underwriter waives its right of first refusal, any deviation
from such terms (including without limitation after the launch of a subsequent transaction) shall void the waiver and require the Company
to seek a new waiver from the right of first refusal on the terms set forth in this Section 5.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B><U>Covenants of the Underwriter</U></B>. The Underwriter hereby covenants and agrees with the Company
as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">6.1. <B><U>Underwriter
Free Writing Prospectus</U></B>. The Underwriter has not used, authorized the use of, referred to or participated in the planning
for use of, and will not use, authorize the use of, refer to or participate in the planning for use of, any Free Writing Prospectus
(which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference
into the Registration Statement and any press release issued by the Company) other than (i) a Free Writing Prospectus that contains
no &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule 433(d) under the Securities Act
(&ldquo;<B><U>Issuer Information</U></B>&rdquo;) that was not included in the Preliminary Prospectus Supplement or a previously
filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed in Schedule 2.5.4 hereto or prepared pursuant
to Section 2.5.4 or Section 5.4 hereof (including any electronic road show), or (iii) any Free Writing Prospectus prepared by the
Underwriter and approved by the Company in advance in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">6.2.   <B><U>Section
8A Proceedings</U></B>. The Underwriter is not subject to any pending proceeding under Section 8A of the Securities Act with respect to
the offering of the Shares and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery
Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B><U>Payment of Expenses</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">7.1.   <B><U>Company
Expenses</U></B>. The Company hereby agrees to pay on the Closing Date all expenses incident to the performance of the obligations of
the Company under this Agreement including, but not limited to: (a) all filing fees and expenses relating to the registration of the Shares
with the Commission; (b) all filing fees and expenses associated with the review of the offering of the Shares by FINRA; (c) all fees
and expenses relating to the listing of the Shares on the Exchange (to the extent relevant) or on such other stock exchanges as the Company
and the Underwriter together determine; (d) all fees, expenses and disbursements relating to the registration or qualification of the
Shares under the &ldquo;blue sky&rdquo; securities laws of such states and other jurisdictions as the Underwriter may reasonably designate
(including, without limitation, all filing and registration fees, and the reasonable fees and disbursements of the Company&rsquo;s &ldquo;blue
sky&rdquo; counsel, which will be Underwriter&rsquo;s counsel) unless such filings are not required in connection with the Company&rsquo;s
proposed Exchange listing; (e) all fees, expenses and disbursements relating to the registration, qualification or exemption of the Securities
under the securities laws of such foreign jurisdictions as the Underwriter may reasonably designate; (f) the costs of all mailing and
printing of the underwriting documents, the Registration Statement, Pricing Disclosure Package, the Final Prospectus Supplement, any Preliminary
Prospectus Supplement, any Issuer Free Writing Prospectus or any Testing-the-Waters Communication and all amendments, supplements and
exhibits thereto as the Underwriter may reasonably deem necessary; (g) the costs of preparing, printing and delivering certificates representing
the Shares; (h) fees and expenses of the transfer agent for the Shares; (i) transfer and/or stamp taxes, if any, payable upon the transfer
of securities from the Company to the Underwriter; (j) the fees and expenses of the Company&rsquo;s accountants; and (k) reasonable legal
fees and disbursements for the Underwriter&rsquo;s counsel. The total amount payable by the Company pursuant to (k) to the Underwriter
shall not exceed $100,000. The Underwriter may deduct from the net proceeds of the Offering payable to the Company on the Closing Date
the expenses set forth herein to be paid by the Company to the Underwriter. Except as provided for in this Agreement, the Underwriter
shall bear the costs and expenses incurred by them in connection with the sale of the Shares and the transactions contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">7.2.   <B><U>Underwriter
Expenses</U></B>. Except to the extent otherwise provided in this Section 7 or Section 9 hereof, the Underwriter will pay all of its own
costs and expenses, including the fees and expenses of their counsel, any stock transfer taxes on resale of any of the Shares held by
them, and any advertising expenses connected with any offers they may make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">7.3.   <B><U>Non-accountable
Expenses</U></B>. On the Closing Date and any Additional Closing Date, the Company shall pay to the Underwriter, by deduction from the
net proceeds of the offering a non-accountable expense allowance equal to seventy-five hundredths of a percent (0.75%) of the gross proceeds
received by the Company from the sale of the Closing Shares, Pre-funded Warrants or the Option Shares, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">7.4.   <B><U>Company
Reimbursement</U></B>. The provisions of this Section 7 shall not affect any agreement that the Company may make for the sharing of such
costs and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B><U>Conditions of the Obligations of the Underwriter</U></B>. The obligations of the Underwriter to
purchase the Closing Shares and the Closing Pre-funded Warrants as provided herein on the Closing Date or the Option Shares as provided
herein on any Additional Closing Date, as the case may be, shall be subject to the timely performance by the Company of its covenants
and other obligations hereunder, and to each of the following additional conditions:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.1.   <B><U>Registration
Compliance; No Stop Order</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">8.1.1.   The
Registration Statement and any post-effective amendment thereto shall have become effective, no stop order suspending the effectiveness
of the Registration Statement or any post-effective amendment thereto shall be in effect, and no proceeding for such purpose or pursuant
to Section 8A of the Securities Act shall be pending before or threatened by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">8.1.2.   The
Company shall have filed the Final Prospectus Supplement and each Issuer Free Writing Prospectus with the Commission in accordance with
and within the time periods prescribed by Section 5.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">8.1.3.   The
Company shall have (A) disclosed to the Underwriter all requests by the Commission for additional information relating to the offer and
sale of the Shares and (B) complied with such requests to the reasonable satisfaction of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.2.   <B><U>Representations
and Warranties</U></B>. The representations and warranties of the Company contained herein shall be true and correct on the date hereof
and on and as of the Closing Date or any Additional Closing Date, as the case may be, and the statements of the Company and its officers
made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or any Additional
Closing Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.3. <B><U>Auditor
Comfort Letters</U></B>. On the Closing Date or any Additional Closing Date, as the case may be, Audit Alliance LLP shall have
furnished to the Underwriter, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed
to the Underwriter, in form and substance reasonably satisfactory to the Underwriter, containing statements and information of the
type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial
statements and certain financial information contained in each of the Registration Statement, the Pricing Disclosure Package and the
Final Prospectus Supplement; <U>provided</U> that the letter delivered on the Closing Date or any Additional Closing Date, as the
case may be, shall use a &ldquo;cut-off&rdquo; date no more than two business days prior to the Closing Date or such Additional
Closing Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.4.   <B><U>No
Material Adverse Change</U></B>. No event or condition of a type described in Section 2.13 hereof shall have occurred or shall exist,
which event or condition is not described in each of the Pricing Disclosure Package and the Final Prospectus Supplement (in each case,
exclusive of any amendment or supplement thereto), the effect of which in the judgment of the Underwriter makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Shares on the Closing Date or any Additional Closing Date, as the case may be, in
the manner and on the terms contemplated by this Agreement, the Pricing Disclosure Package and the Final Prospectus Supplement (in each
case, exclusive of any amendment or supplement thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.5.   <B><U>Opinion
and Negative Assurance Letter of Counsel to the Company</U></B>. U.S. Company Counsel and Foreign Counsel shall each have furnished to
the Underwriter, at the request of the Company, its (i) written opinion, addressed to the Underwriter and dated the Closing Date or any
Additional Closing Date, as the case may be, and (ii) negative assurance letter, addressed to the Underwriter and dated the Closing Date
or any Additional Closing Date, as the case may be, in each case, in a form reasonably satisfactory to the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.6. <B><U>Officer&rsquo;s
Certificate</U></B>. The Underwriter shall have received as of the date of this Agreement, the Closing Date or any Additional
Closing Date on the date of this Agreement, a certificate from the Company&rsquo;s CFO in form and substance reasonably satisfactory
to the Underwriter, containing statements and information confirming that the financial statements and certain financial information
contained in the Registration Statement is consistent with the Company&rsquo;s records and does not contain any material
misstatements or omissions and shall have received as of the Closing Date or any Additional Closing Date, as the case may be, a
certificate of an executive officer of the Company who has specific knowledge of the Company&rsquo;s financial matters and is
satisfactory to the Underwriter, (i) confirming that such officer has carefully reviewed the Registration Statement, the Pricing
Disclosure Package, the Final Prospectus Supplement, each Issuer Free Writing Prospectus and each Written Testing-the-Waters
Communication and, to the knowledge of such officer, the representations set forth in Sections 2.1.2, 2.2, 2.3.1, 2.4.1, 2.5.1, 2.6
and 2.8, hereof are true and correct on and as of the Closing Date or any Additional Closing Date, as the case may be; (ii) to the
effect set forth in clause (i) of Section 2.11 and Section 8.1 hereof; and (iii) confirming that all of the other representations
and warranties of the Company in this Agreement are true and correct on and as of the Closing Date or any Additional Closing Date,
as the case may be, and that the Company has complied with all agreements and covenants and satisfied all other conditions on its
part to be performed or satisfied hereunder at or prior to the Closing Date or any Additional Closing Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.7.   <B><U>No
Legal Impediment to Issuance and Sale</U></B>. No action shall have been taken and no statute, rule, regulation or order shall have been
enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or
any Additional Closing Date, as the case may be, prevent the issuance, sale or delivery of the Closing Shares, the Closing Pre-funded
Warrants or the Option Shares by the Company; and no injunction or order of any federal, state or foreign court shall have been issued
that would, as of the Closing Date or any Additional Closing Date, as the case may be, prevent the issuance, sale or delivery of the Closing
Shares, the Closing Pre-funded Warrants or the Option Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.8.   <B><U>Good
Standing</U></B>. The Underwriter shall have received on and as of the Closing Date and any Additional Closing Date, as the case may be,
satisfactory evidence of the good standing of the Company in its jurisdiction of incorporation, in writing from the appropriate governmental
authorities of such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.9.   <B><U>Lock-Up
Agreements</U></B>. The Lock-Up Agreements substantially in the form of <B><U>Exhibit 8.9</U></B> hereto executed by the officers, directors
and certain shareholders of the Company relating to sales and certain other dispositions of Ordinary Shares or certain other securities,
delivered to the Underwriter on or before the date hereof, shall be in full force and effect on the Closing Date or any Additional Closing
Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.10.   <B><U>Exchange
Listing</U></B>. On the Closing Date or any Additional Closing Date, as the case may be, the Shares shall have been approved for listing
on the Exchange, subject to notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.11.   <B><U>Additional
Documents</U></B>. On or prior to the Closing Date or any Additional Closing Date, as the case may be, the Underwriter and its counsel
shall have received such information, certificates and other additional documents from the Company as they may reasonably require for
the purpose of enabling them to pass upon the issuance and sale of the Shares as contemplated herein or in order to evidence the accuracy
of any of the representations and warranties, or the satisfaction of any of the covenants, closing conditions or other obligations, contained
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, certificates
and other documents delivered pursuant to this Agreement will be deemed to be in compliance with the provisions hereof only if they are
reasonably satisfactory in form and substance to counsel for the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any condition
specified in this Section 8 is not satisfied when and as required to be satisfied, this Agreement and all obligations of the
Underwriter hereunder may be terminated by the Underwriter by notice to the Company at any time on or prior to the Closing Date or
any Additional Closing Date, as the case may be, which termination shall be without liability on the part of any party to any other
party, except that the Company shall continue to be liable for the payment of expenses under Section 7 and Section 12 hereof and
except that the provisions of Section 9 and Section 10 hereof shall at all times be effective and shall survive any such
termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B><U>Indemnification</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.1.   <B><U>Indemnification
of the Underwriter by the Company</U></B>. The Company agrees to indemnify and hold harmless the Underwriter, its Affiliates, directors,
officers, employees and agents and each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages and liabilities (including, without limitation,
all reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such
fees and expenses are incurred), joint or several, that arise out of or are based upon (i) any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement (or any amendment or supplement thereto), or the omission or alleged omission
therefrom of a material fact required to be stated therein or necessary in order to make the statements therein not misleading, or (ii)
any untrue statement or alleged untrue statement of a material fact contained in any Pricing Disclosure Package (including any Pricing
Disclosure Package that has subsequently been amended), the Final Prospectus Supplement (or any amendment or supplement thereto), any
Preliminary Prospectus Supplement, any Issuer Information, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication
or any Road Show, or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading, in each case, except insofar as such losses, claims, damages
or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance
upon and in conformity with the Underwriter Information. The indemnity agreement set forth in this Section 9.1 shall be in addition to
any liabilities that the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.2.   <B><U>Indemnification
of the Company by the Underwriter</U></B>. The Underwriter agrees to indemnify and hold harmless the Company, its directors, each officer
who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages and liabilities (including, without limitation,
all reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such
fees and expenses are incurred), joint or several, to the same extent as the indemnity set forth in Section 9.1 hereof; provided, however,
that the Underwriter shall be liable only to the extent that any untrue statement or omission or alleged untrue statement or omission
was made in the Registration Statement (or any amendment or supplement thereto), any Pricing Disclosure Package (including any Pricing
Disclosure Package that has subsequently been amended), the Final Prospectus Supplement (or any amendment or supplement thereto), any
Preliminary Prospectus Supplement, any Issuer Information, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication
or any Road Show in reliance upon, and in conformity with, the Underwriter Information relating to the Underwriter. The indemnity agreement
set forth in this Section 9 shall be in addition to any liabilities that the Underwriter may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.3.   <B><U>Notifications
and Other Indemnification Procedures</U></B>. If any suit, action, proceeding (including any governmental or regulatory investigation),
claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to any of the
preceding subsections of this Section 9, such person (the &ldquo;<B><U>Indemnified Person</U></B>&rdquo;) shall promptly notify the person
against whom such indemnification may be sought (the &ldquo;<B><U>Indemnifying Person</U></B>&rdquo;) in writing; <U>provided</U> that
the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under any of the preceding subsections
of this Section 9 except to the extent that it has been materially prejudiced by such failure; and <U>provided</U>, further, that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise
than under any of the preceding subsections of this Section 9. If any such proceeding shall be brought or asserted against an Indemnified
Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory
to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent
the Indemnified Person in such proceeding and shall pay the reasonable and documented fees and expenses of such counsel related to such
proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person
shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably
satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses
available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any
such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of
both parties by the same counsel would be inappropriate due to actual or potential differing interest between them. It is understood and
agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable
for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all
such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for (i) the Underwriter, its Affiliates,
directors, officers, employees and agents and each person, if any, who controls the Underwriter within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act shall be designated in writing by the Underwriter; and (ii) the Company, its directors,
its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act shall be designated in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.4. <B><U>Settlements</U></B>.
The Indemnifying Person under this Section 9 shall not be liable for any settlement of any proceeding effected without its written
consent, which consent may not be unreasonably withheld, but if settled with such consent or if there be a final judgment for the
plaintiff, the Indemnifying Person agrees to indemnify the Indemnified Person from and against any loss, claim, damage, liability or
expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall
have requested an Indemnifying Person to reimburse the Indemnified Person for any reasonably incurred and documented fees and
expenses of counsel as contemplated by this Section 9, the Indemnifying Person agrees that it shall be liable for any settlement of
any proceeding effected without its written consent if (i) such settlement is entered into more than forty-five (45) days after
receipt by such Indemnifying Person of the aforesaid request, (ii) such Indemnifying Person shall not have reimbursed the
Indemnified Person in accordance with such request, or shall not have disputed in good faith the Indemnified Person&rsquo;s
entitlement to such reimbursement, prior to the date of such settlement and (iii) such Indemnified Person shall have given the
Indemnifying Person at least forty-five (45) days&rsquo; prior notice of its intention to settle. No Indemnifying Person shall,
without the prior written consent of the Indemnified Person effect any settlement, compromise or consent to the entry of judgment in
any pending or threatened action, suit or proceeding in respect of which any Indemnified Person is or could have been a party and
indemnity was or could have been sought hereunder by such Indemnified Person, unless such settlement, compromise or consent (x)
includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified
Person, from and against all liability on claims that are the subject matter of such action, suit or proceeding and (y) does not
include any statements as to or any findings of fault, culpability or failure to act by or on behalf of any Indemnified Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B><U>Contribution</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.1.   To
the extent the indemnification provided for in Section 9 hereof is unavailable to or insufficient to hold harmless an Indemnified Person
in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each Indemnifying Person, in lieu of indemnifying
such Indemnified Person thereunder, shall contribute to the aggregate amount paid or payable by such Indemnified Person, as incurred,
as a result of any losses, claims, damages, liabilities or expenses referred to therein (i) in such proportion as is appropriate to reflect
the relative benefits received by the Company, on the one hand, and the Underwriter, on the other hand, from the offering of the Shares
pursuant to this Agreement or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company,
on the one hand, and the Underwriter, on the other hand, in connection with the statements or omissions that resulted in such losses,
claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits received by the
Company, on the one hand, and the Underwriter, on the other hand, in connection with the offering of the Shares pursuant to this Agreement
shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Shares pursuant to this Agreement
(before deducting expenses) received by the Company, on the one hand, and the total underwriting discounts and commissions received by
the Underwriter, on the other hand, in each case as set forth in the table on the cover of the Final Prospectus Supplement bear to the
aggregate initial offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriter, on the other
hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission
or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Underwriter, on the
other hand, and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such statement
or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.2.   The
amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed
to include, subject to the limitations set forth in Section 9 hereof, all reasonable legal or other fees or expenses incurred by such
party in connection with investigating or defending any action or claim. The provisions set forth in Section 9 hereof with respect to
notice of commencement of any action shall apply if a claim for contribution is to be made under this Section 10; <U>provided</U>, however,
that no additional notice shall be required with respect to any action for which notice has been given under Section 9 hereof for purposes
of indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.3.   The
Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to this Section 10 was determined by
pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in this
Section 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.4.   Notwithstanding
the provisions of this Section 10, the Underwriter shall not be required to contribute any amount in excess of the amount by which the
total discounts and commissions received by the Underwriter in connection with the Shares distributed by it exceeds the amount of any
damages the Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement or omission or
alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11 of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.5.   For
purposes of this Section 10, each director, officer, employee and agent of the Underwriter and each person, if any, who controls the Underwriter
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as
the Underwriter, and each director and officer of the Company who signed the Registration Statement, and each person, if any, who controls
the Company with the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to contribution
as the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">10.6.   The
remedies provided for in Section 9 and Section 10 hereof are not exclusive and shall not limit any rights or remedies which may otherwise
be available to any Indemnified Person at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B><U>Termination</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">11.1. Prior to
the delivery of and payment for the Shares on the Closing Date or any Additional Closing Date, as the case may be, this Agreement
may be terminated by the Underwriter in the absolute discretion of the Underwriter by notice given to the Company if after the
execution and delivery of this Agreement: (i) trading or quotation of any securities issued or guaranteed by the Company shall have
been suspended or materially limited on any securities exchange, quotation system or in the over-the-counter market; (ii) trading in
securities generally on any of the New York Stock Exchange, the Nasdaq Stock Exchange or the over-the-counter market shall have been
suspended or materially limited; (iii) a general banking moratorium on commercial banking activities shall have been declared by
federal or New York state authorities; (iv) there shall have occurred a material disruption in commercial banking or securities
settlement, payment or clearance services in the United States; (v) there shall have occurred any outbreak or escalation of national
or international hostilities or any crisis or calamity, or any change in the United States or international financial markets, or
any substantial change or development involving a prospective substantial change in general economic, financial or political
conditions in the United States or internationally, as in the judgment of the Underwriter is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or any Additional
Closing Date, as the case may be, in the manner and on the terms described in the Pricing Disclosure Package or to enforce contracts
for the sale of securities; or (vi) the Company or any of its subsidiaries shall have sustained a loss by strike, fire, flood,
earthquake, accident or other calamity of such character as in the judgment of the Underwriter may interfere materially with the
conduct of the business and operations of the Company and its subsidiaries, considered as one entity, regardless of whether or not
such loss shall have been insured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">11.2.   Any
termination pursuant to this Section 11 shall be without liability on the part of: (x) the Company to the Underwriter, except that the
Company shall continue to be liable for the payment of expenses under Section 7; (y) the Underwriter to the Company; or (z) any party
hereto to any other party except that the provisions of Section 9, Section 10 and this Section 11 hereof shall at all times be effective
and shall survive any such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B><U>Reimbursement of the Underwriter&rsquo;s Expenses</U></B>. If (a) the Company fails to deliver the
Shares to the Underwriter for any reason at the Closing Date or any Additional Closing Date, as the case may be, in accordance with this
Agreement or (b) the Underwriter declines to purchase the Shares for any reason permitted under this Agreement, then the Company agrees
to reimburse the Underwriter for all reasonable out-of-pocket costs and expenses (including the reasonable and documented fees and expenses
of counsel to the Underwriter) incurred by the Underwriter in connection with this Agreement and the applicable offering contemplated
hereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B><U>Representations and Indemnities to Survive Delivery</U></B>. The respective indemnities, rights
of contribution, agreements, representations, warranties and other statements of the Company and the Underwriter set forth in or made
pursuant to this Agreement or made by or on behalf of the Company or the Underwriter pursuant to this Agreement or any certificate delivered
pursuant hereto shall remain in full force and effect, regardless of any investigation made by or on behalf of the Underwriter, the Company
or any of their respective officers or directors or any controlling person, as the case may be, and shall survive delivery of and payment
for the Shares sold hereunder and any termination of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><B><U>Notices</U></B>. All notices, requests, consents, claims, demands, waivers and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given (i) when delivered by hand (with written confirmation
of receipt), (ii) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested), (iii) on the
date sent by facsimile (with confirmation of transmission) or email of a PDF document if sent during normal business hours of the recipient,
and on the next Business Day if sent after normal business hours of the recipient, or (iv) on the third day after the date mailed, by certified
or registered mail (in each case, return receipt requested, postage pre-paid). Such communications must be sent to the respective parties
at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section
14):</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>If to the Underwriter:</TD>
    <TD COLSPAN="2">Aegis Capital Corp.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">1345 Avenue of the Americas, 27th Floor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">New York, NY 10105</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 8%">Email:</TD>
    <TD STYLE="width: 74%">reide@aegiscap.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attention:&nbsp;</TD>
    <TD>Robert Eide</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>with a copy to:</TD>
    <TD COLSPAN="2">Kaufman &amp; Canoles, P.C.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Two James Center, 14th Floor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">1021 E. Cary St.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Richmond, VA 23219</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>awbasch@kaufcan.com <FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attention:</TD>
    <TD>Anthony Basch</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>If to the Company:</TD>
    <TD COLSPAN="2">61 Robinson Road Level 6 &amp; 7</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">#738, Singapore 068893</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>alan@btct.us</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attention:</TD>
    <TD>Siguang Peng</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>with copy to:</TD>
    <TD COLSPAN="2">VCL Law LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">1945 Old Gallows Road, Suite 260</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Vienna, VA 22182</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>fliu@vcllegal.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Attention:</TD>
    <TD>Fang Liu</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">Any party hereto may change
the address or facsimile number for receipt of communications by giving written notice to the others in accordance with this Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B><U>Successors</U></B>. This Agreement shall inure solely to the benefit of and be binding upon the
Underwriter, the Company and the other indemnified parties referred to in Section 9 and Section 10 hereof, and in each case their respective
successors. Nothing in this Agreement is intended, or shall be construed, to give any other person or entity any legal or equitable right,
benefit, remedy or claim under, or in respect of or by virtue of, this Agreement or any provision contained herein. The term &ldquo;successors,&rdquo;
as used herein, shall not include any purchaser of the Shares from the Underwriter merely by reason of such purchase.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><B><U>Partial Unenforceability</U></B>. The invalidity or unenforceability of any Section, paragraph or
provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any
Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to
be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><B><U>Governing Law</U></B>. This Agreement and any claim, controversy or dispute arising under or related
to this Agreement, whether sounding in contract, tort or statute, shall be governed by and construed in accordance with the internal laws
of the State of New York applicable to agreements made and to be performed in such state (including its statute of limitations), without
giving effect to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application
of the laws of any jurisdiction other than those of the State of New York. The Company has irrevocably appointed Greg Campbell, as its
agent to receive service of process or other legal summons for purposes of any such suit, action or proceeding that may be instituted
in any state or federal court in the Borough of Manhattan in the City of New York, United States of America.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><B><U>Consent to Jurisdiction</U></B>. No legal suit, action or proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby (each, a &ldquo;<B><U>Related Proceeding</U></B>&rdquo;) may be commenced, prosecuted
or continued in any court other than the courts of the State of New York located in the City and County of New York or in the United States
District Court for the Southern District of New York, which courts (collectively, the &ldquo;<B><U>Specified Courts</U></B>&rdquo;) shall
have jurisdiction over the adjudication of any Related Proceeding, and the parties to this Agreement hereby irrevocably consent to the
exclusive jurisdiction the Specified Courts and personal service of process with respect thereto. The parties to this Agreement hereby
irrevocably waive any objection to the laying of venue of any Related Proceeding in the Specified Courts and irrevocably waive and agree
not to plead or claim in any Specified Court that any Related Proceeding brought in any Specified Court has been brought in an inconvenient
forum.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">19.</TD><TD STYLE="text-align: justify"><B><U>Equitable Remedies</U></B>. Each party to this Agreement acknowledges and agrees that (a) a breach
or threatened breach by the Company of any of its obligations under Sections 5.10 and 5.15 would give rise to irreparable harm to the
Underwriter for which monetary damages would not be an adequate remedy and (b) if a breach or a threatened breach by the Company of any
such obligations occurs, the Underwriter will, in addition to any and all other rights and remedies that may be available to such party
at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an
injunction, specific performance of the terms of Sections 5.10 and 5.15 and any other relief that may be available from a court of competent
jurisdiction, without any requirement to (i) post a bond or other security, or (ii) prove actual damages or that monetary damages will
not afford an adequate remedy. Each party to this Agreement agrees that such party shall not oppose or otherwise challenge the existence
of irreparable harm, the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable
relief, in either case, consistent with the terms of this Section 19.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">20.</TD><TD STYLE="text-align: justify"><B><U>Waiver of Jury Trial</U></B>. The parties to this Agreement hereby irrevocably waive, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any Related Proceeding.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">21.</TD><TD STYLE="text-align: justify"><B><U>No Fiduciary Relationship</U></B>. The Company acknowledges
and agrees that: (i) the purchase and sale of the Shares pursuant to this Agreement, including the determination of the offering price
of the Shares and any related discounts and commissions, is an arm&rsquo;s-length commercial transaction between the Company, on the
one hand, and the Underwriter, on the other hand; (ii) in connection with each transaction contemplated hereby and the process leading
to such transaction the Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company or
its Affiliates, shareholders, members, partners, creditors or employees or any other party; (iii) the Underwriter has not assumed and
will not assume an advisory or fiduciary responsibility in favor of the Company with respect to any of the transactions contemplated
hereby or the process leading thereto (irrespective of whether the Underwriter has advised or is currently advising the Company on other
matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement; (iv) the Underwriter and
its respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company,
and the Underwriter has no obligation to disclose any of such interests by virtue of any fiduciary or advisory relationship; and (v)
the Underwriter has not provided any legal, accounting, regulatory or tax advice in any jurisdiction with respect to the offering contemplated
hereby, and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent they deemed appropriate. The
Company waives and releases, to the full extent permitted by applicable law, any claims it may have against the Underwriter arising from
an alleged breach of fiduciary duty in connection with the offering of the Shares or any matters leading up to the offering of the Shares.</TD>
</TR></TABLE>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">22.</TD><TD STYLE="text-align: justify"><B><U>Compliance with the USA Patriot Act</U></B>. In accordance with the requirements of the USA Patriot
Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriter is required to obtain, verify and record information
that identifies their respective clients, including the Company, which information may include the name and address of its clients, as
well as other information that will allow the Underwriter to properly identify their respective clients.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify"><B><U>Entire Agreement</U></B>. This Agreement, together with any contemporaneous written agreements and
any prior written agreements (to the extent not superseded by this Agreement) that relate to the offering of the Shares, represents the
entire agreement among the Company and the Underwriter with respect to the preparation of the Registration Statement, the Pricing Disclosure
Package, the Final Prospectus Supplement, each Preliminary Prospectus Supplement, each Issuer Free Writing Prospectus, each Testing-the-Waters
Communication and each Road Show, the purchase and sale of the Shares and the conduct of the offering contemplated hereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify"><B><U>Amendments or Waivers</U></B>. No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by all
the parties hereto. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not
expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after the waiver.
No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be
construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any
other or further exercise of any other right, remedy, power or privilege.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify"><B><U>Section Headings</U></B>. The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify"><B><U>Counterparts</U></B>. This Agreement may be executed in counterparts, each of which will be deemed
an original, but all of which together will be deemed to be one and the same agreement. Counterparts may be delivered via facsimile, email
(including PDF or any electronic signature complying with the U.S. federal ESIGN Act of 2000) or other transmission method, and any counterpart
so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify"><B><U>Recognition of the U.S. Special Resolution Regimes</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">27.1.   In
the event that the Underwriter is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective
to the same extent as the transfer would be effective under the U.S. Special Resolution Regime (as defined below) if this Agreement, and
any such interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">27.2.   In
the event that the Underwriter is a Covered Entity or a BHC Act Affiliate (as defined below) of the Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against the Underwriter
is permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime
if this Agreement were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">27.3.   As
used in this section:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">27.3.1.   &ldquo;<B><U>BHC
Act Affiliate</U></B>&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with,
12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">27.3.2.   &ldquo;<B><U>Covered
Entity</U></B>&rdquo; means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">27.3.2.1   a
&ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">27.3.2.2   a
&ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">27.3.2.3   a
&ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">27.3.3.   &ldquo;<B><U>Default
Right</U></B>&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81,
47.2 or 382.1, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">27.3.4. &ldquo;<B><U>U.S.
Special Resolution Regime</U></B>&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii) Title II of the Dodd- Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[BTCT Underwriting Agreement Signature Page
Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[BTCT Underwriting Agreement Signature Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">If the foregoing is in accordance
with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Very truly yours,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BTC Digital Ltd.</B></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%; text-align: left; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%; text-align: left; font-size: 10pt">/s/ Siguang Peng</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; font-size: 10pt">Name:&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; font-size: 10pt">Siguang Peng</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; text-align: left; font-size: 10pt">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Confirmed and accepted as of the date first above
written:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>AEGIS CAPITAL CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; text-align: left; font-size: 10pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom; text-align: left; font-size: 10pt; width: 35%">/s/ Robert Eide</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; font-size: 10pt">Name:&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Robert Eide</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; font-size: 10pt">Title:</TD>
    <TD STYLE="text-align: left; font-size: 10pt">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 1.18</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pricing Disclosure Package </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Number of Closing Shares:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Number of Closing Pre-funded Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Number of Option Shares:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Number of Option Pre-funded Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Public Offering Price per Closing Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Public Offering Price per Closing Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Exercise Price per Pre-Funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Underwriting Discount per Common Share and per Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-accountable expense allowance per Common Share and per Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.060</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Purchase Price per Option Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Purchase Price per Option Pre-Funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.379</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 2.5.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Free Writing Prospectuses </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 2.43</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Principal Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"><B>Principal Subsidiaries</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Place of Incorporation</B></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left">[&#9679;]</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">[&#9679;]</TD></TR>
  <TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 4.1.2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Closing Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Underwriter</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Closing Shares to Be Purchased</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Closing Pre-funded Warrants to Be Purchased</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Option Shares to Be Purchased if the Maximum Over-Allotment Option Is Exercised</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-bottom: 1.5pt">Aegis Capital Corp.</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,000,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,500,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">375,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT 5.10.3.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Waiver </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[&#9679;], 202[&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[Waiver Recipient Name and Address]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Re: Lock-Up Agreement Waiver</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[Pursuant to Section 8.9 of the Underwriting Agreement,
dated December 6, 2024 (the &ldquo;<B><U>Underwriting Agreement</U></B>&rdquo;), among BTC Digital Ltd., a Cayman Islands exempted company
(the &ldquo;<B><U>Company</U></B>&rdquo;), and Aegis Capital Corp. (the &ldquo;<B><U>Underwriter</U></B>&rdquo;), and the Lock-Up Agreement,
dated December 6, 2024 (the &ldquo;<B><U>Lock-Up Agreement</U></B>&rdquo;), between you and the Underwriter relating to the Company&rsquo;s
Ordinary Shares, without par value per share (the &ldquo;<B><U>Share</U></B>&rdquo;), the Underwriter hereby gives its consent to allow
you to sell up to [&#9679;] Shares [solely from and including [DATE] to and including [DATE]].]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[Pursuant to Section 5.10 of the Underwriting
Agreement, the Underwriter hereby gives its consent to allow the Company to issue and sell up to [&#9679;] Shares pursuant to an offering
of the Shares to commence prior to the expiration of the Lock-Up Period as defined in the Underwriting Agreement[, provided that such
offering closes on or prior to [&#9679;]].]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">AEGIS CAPITAL CORP.</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Name:&nbsp;</TD>
    <TD STYLE="text-align: left">Robert Eide</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Title:</TD>
    <TD STYLE="text-align: left">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT 5.10.3.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Waiver Press Release </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BTC DIGITAL LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>[Date] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BTC DIGITAL LTD., a Cayman Islands exempted company
(the &ldquo;Company&rdquo;) announced today that Aegis Capital Corp., acting as the Underwriter in the Company&rsquo;s recent public offering
of the Company&rsquo;s Shares, is [waiving] [releasing] a lock-up restriction with respect to the Company&rsquo;s Ordinary shares held
by [certain officers or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on [Date], and the
Shares may be sold on or after such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This press release is not an offer or sale
of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not
be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT 8.9 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea022404301ex4-1_btcdigi.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="text-align: right; margin: 0"><b>Exhibit 4.1</b></p>

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTERED PRE-FUNDED WARRANT TO PURCHASE ORDINARY
SHARES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BTC DIGITAL LTD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; font-size: 10pt">Warrant Shares: [&#9679;]</td>
    <td style="width: 20%; font-size: 10pt">Initial Exercise Date:</td>
    <td style="width: 30%; font-size: 10pt">December 6, 2024</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt">Issuance Date:</td>
    <td style="font-size: 10pt">December 9, 2024</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>THIS PRE-FUNDED WARRANT
TO PURCHASE ORDINARY SHARES</b> (the &ldquo;<b><u>Warrant</u></b>&rdquo;) certifies that, for value received, [&#9679;] or its assigns
(the &ldquo;<b><u>Holder</u></b>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time until this Warrant is exercised in full (the &ldquo;<b><u>Termination Date</u></b>&rdquo;) , to subscribe for and
purchase from BTC Digital Ltd., a Cayman Islands corporation (the &ldquo;<b><u>Company</u></b>&rdquo;), up to [&#9679;] ordinary shares
(as subject to adjustment hereunder, the &ldquo;<b><u>Warrant Shares</u></b>&rdquo;). The purchase price of one (1) Ordinary Share under
this Warrant shall be equal to the Exercise Price, as defined in Section 2.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">1.</td><td style="text-align: justify"><b><u>Definitions</u></b>. In addition to the terms defined elsewhere in this Warrant or in the Underwriting
Agreement dated December 6, 2024 by and among the Company and the investors (the &ldquo;<b><u>Purchasers</u></b>&rdquo;) referred to therein
(the &ldquo;<b><u>Securities Purchase Agreement</u></b>&rdquo;), the following terms have the meanings indicated in this Section 1:</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.1. <b><u>Affiliate</u></b>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.2. <b><u>Bid
Price</u></b>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary
Shares are then listed or quoted on a Trading Market, the bid price of the Ordinary Shares for the time in question (or the nearest preceding
date) on the Trading Market on which the Ordinary Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Ordinary Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Ordinary
Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on the Pink
Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Ordinary
Share so reported, or (d)&nbsp;in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.3. <b><u>Board
of Directors</u></b>&rdquo; means the board of directors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.4. <b><u>Business
Day</u></b>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.5. <b><u>Commission</u></b>&rdquo;
means the United States Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.6. <b><u>Exchange
Act</u></b>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.7. <b><u>Ordinary
Share</u></b>&rdquo; means the ordinary shares of the Company, $0.06 par value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.8. <b><u>Ordinary
Share Equivalents</u></b>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Ordinary Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.9. <b><u>Person</u></b>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.10. <b><u>Registration
Statement</u></b>&rdquo; means the Company&rsquo;s registration statement on Form S-3 (File No. 333-283367).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.11. <b><u>Securities
Act</u></b>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.12. <b><u>Subsidiary</u></b>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.13. <b><u>Trading
Day</u></b>&rdquo; means a day on which the Ordinary Shares are traded on a Trading Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.14. <b><u>Trading
Market</u></b>&rdquo; means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.15. <b><u>Transaction
Documents</u></b>&rdquo; means the Underwriting Agreement, these Warrants, other Warrants as contemplated in the Underwriting Agreement,
the Lock-Agreement and all exhibits and schedules thereto and hereto and any other documents agreements executed in connection with the
transactions contemplated hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.16. <b><u>Transfer
Agent</u></b>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street, 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.17. <b><u>Underwriting
Agreement</u></b>&rdquo; means the underwriting agreement, dated as of December 6, 2024, between the Company and Aegis Capital Corp.,
as amended, modified or supplemented from time to time in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.18. <b><u>VWAP</u></b>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Shares are then listed
or quoted on a Trading Market, the daily volume weighted average price of the Ordinary Shares for such date (or the nearest preceding
date) on the Trading Market on which the Ordinary Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Ordinary Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Ordinary Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported on
the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per Ordinary Share so reported, or (d)&nbsp;in all other cases, the fair market value of an Ordinary Share as determined by an independent
appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to
the Company, the fees and expenses of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.19. <b><u>Warrants</u></b>&rdquo;
means this Warrant and other Ordinary Shares purchase warrants issued by the Company pursuant to the Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">2.</td><td style="text-align: justify"><b><u>Exercise</u></b>.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.1. <b><u>Exercise
of Warrant</u></b>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise substantially in the form attached hereto as Exhibit <u>2.1</u> (the &ldquo;<b><u>Notice
of Exercise</u></b>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2.4.1 herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on
a United States bank unless the cashless exercise procedure specified in Section 2.3 below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days after the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <b>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.2. <b><u>Exercise
Price</u></b>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, subject
to adjustment hereunder (such nominal exercise price, the &ldquo;<b><u>Exercise Price</u></b>&rdquo;), was pre-funded to the Company on
or prior to the Initial Exercise Date and, consequently, no additional consideration (other than such Exercise Price) shall be required
to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund
of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.3. <b><u>Cashless
Exercise</u></b>. This Warrant may also be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which the
Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.5in">(A) =</td><td style="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2.1 hereof on a day that is not a Trading Day or (2) delivered
pursuant to Section 2.1 hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the highest Bid Price of the Ordinary
Shares on the principal Trading Market as reported by Bloomberg L.P. within two (2) hours of the time of the Holder&rsquo;s delivery of
the Notice of Exercise pursuant to Section 2.1 hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo;
or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered pursuant to Section
2.1 hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.5in">(B) =</td><td style="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.5in">(X) =</td><td style="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the
terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2.3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.4. <b><u>Mechanics
of Exercise</u></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.1. <b><u>Delivery
of Warrant Shares upon Exercise</u></b>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<b><u>DWAC</u></b>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise and otherwise by physical delivery of a certificate or by
electronic delivery (at the election of the Holder), for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after
the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<b><u>Warrant Share Delivery Date</u></b>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. Notwithstanding
anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall be deemed for purposes of Regulation SHO under
the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery of the Warrant Shares. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such
exercise (based on the VWAP of the Ordinary Shares on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a Transfer Agent
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<b><u>Standard
Settlement Period</u></b>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Ordinary Shares as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the
foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise
Date, which may be delivered at any time after the time of execution of the Underwriting Agreement, the Company agrees to deliver the
Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date
shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in
the case of a cashless exercise) is received by such Warrant Share Delivery Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.2. <b><u>Delivery
of New Warrants Upon Exercise</u></b>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.3. <b><u>Rescission
Rights</u></b>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2.4.1
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.4. <b><u>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</u></b>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2.4.1 above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Ordinary Shares
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<b><u>Buy-In</u></b>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Ordinary Shares so purchased exceeds (y) the amount obtained by
multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at
issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder,
either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored and return
any amount received by the Company in respect of the Exercise Price for those Warrant Shares (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its
exercise and delivery obligations hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.5. <b><u>No
Fractional Shares or Scrip</u></b>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.6. <b><u>Charges,
Taxes and Expenses</u></b>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>,
<u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <u>Exhibit 2.4.6</u> duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.4.7. <b><u>Closing
of Books</u></b>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.5. <b><u>Holder&rsquo;s
Exercise Limitations</u></b>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<b><u>Attribution Parties</u></b>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of Ordinary Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary
Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of
Ordinary Shares which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by
the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of
any other securities of the Company (including, without limitation, any other Ordinary Share Equivalents) subject to a limitation on conversion
or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2.5, beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2.5 applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2.5, in determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as reflected
in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Ordinary
Shares outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing
to the Holder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding Ordinary Shares was reported. The &ldquo;<b><u>Beneficial
Ownership Limitation</u></b>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the
number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares issuable upon exercise of this
Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section
2.5, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Ordinary Shares outstanding immediately
after giving effect to the issuance of Ordinary Shares upon exercise of this Warrant held by the Holder and the provisions of this Section
2.5 shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup>st</sup> day after
such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than
in strict conformity with the terms of this Section 2.5 to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">3.</td><td style="text-align: justify"><b><u>Certain Adjustments</u></b>.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.1. <b><u>Share
Dividends and Splits</u></b>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes
a distribution or distributions on Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which,
for avoidance of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding
Ordinary Shares into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding Ordinary Shares into
a smaller number of shares, or (iv) issues by reclassification of Ordinary Shares any shares of share capital of the Company, then in
each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding
treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Ordinary Shares
outstanding immediately after such event, and the number of Shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3.1 shall
become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.2. <b><u>Subsequent
Rights Offerings</u></b>. In addition to any adjustments pursuant to Section 3.1 above, if at any time the Company grants, issues or sells
any Ordinary Share Equivalents or rights to purchase share, warrants, securities or other property pro rata to all (or substantially all)
of the record holders of any class of Ordinary Shares (the &ldquo;<b><u>Purchase Rights</u></b>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Ordinary
Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time,
if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.3. <b><u>Pro
Rata Distributions</u></b>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of Ordinary Shares, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<b><u>Distribution</u></b>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of Ordinary Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of Ordinary Shares are to be determined for the participation in such Distribution (provided, however,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any Ordinary Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.4. <b><u>Fundamental
Transaction</u></b>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary
Shares or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more
related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share
exchange pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property, or
(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding Ordinary Shares or 50%
or more of the voting power of the common equity of the Company (each a &ldquo;<b><u>Fundamental Transaction</u></b>&rdquo;), then, upon
any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2.5 on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<b><u>Alternate Consideration</u></b>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2.5 on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Ordinary Shares of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Ordinary Shares are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Ordinary Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Ordinary Shares will be deemed to have received common stock/shares of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<b><u>Black Scholes Value</u></b>&rdquo; means the value of this
Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<b><u>Bloomberg</u></b>&rdquo;)
determined as of the day of consummation of the applicable contemplated Fundamental Transaction for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1)
100% and (2) the 100 day volatility as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor)
as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period
beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or
the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant
to this Section 3.4 and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds (or such other consideration) within the later of (i) five (5) Business Days after the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<b><u>Successor Entity</u></b>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3.4
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant that
is exercisable for a corresponding number of shares of share capital of such Successor Entity (or its parent entity) equivalent to the
Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of share
capital (but taking into account the relative value of the Ordinary Shares prior to such Fundamental Transaction and the value of such
shares of share capital, such number of shares of share capital and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3.4 regardless
of (i) whether the Company has sufficient authorized Ordinary Shares for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.5. <B><U>Calculations</U></B>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number
of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.v</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.6. <b><u>Notice
to Holder</u></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.6.1. <b><u>Adjustment
to Exercise Price</u></b>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.6.2. <b><u>Notice
to Allow Exercise by Holder</u></b>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary
Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company
shall authorize the granting to all holders of the Ordinary Share rights or warrants to subscribe for or purchase any shares of share
capital of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification
of the Ordinary Shares, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer
of all or substantially all of its assets, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Ordinary Shares of record shall be entitled to exchange their Ordinary Shares for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">4.</td><td style="text-align: justify"><b><u>Transfer of Warrant</u></b>.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.1. <b><u>Transferability</u></b>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto as Exhibit 2.4.6 duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days after the date on which the Holder delivers an assignment form to
the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
for the purchase of Warrant Shares without having a new Warrant issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.2. <b><u>New
Warrants</u></b>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder
or its agent or attorney. Subject to compliance with Section 4.1, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial Issuance Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.3. <b><u>Warrant
Register</u></b>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<b><u>Warrant
Register</u></b>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">5.</td><td style="text-align: justify"><b><u>Miscellaneous</u></b>.</td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.1. <b><u>No
Rights as Shareholder until Exercise; No Settlement in Cash</u></b>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2.4.1, except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2.3 or to receive cash payments pursuant to Section 2.4.1 and Section 2.4.4 herein, in no event shall the Company be required to net cash
settle an exercise of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.2. <b><u>Loss,
Theft, Destruction or Mutilation of Warrant</u></b>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make
and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.3. <b><u>Saturdays,
Sundays, Holidays, etc</u></b>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.4. <b><u>Authorized
Shares</u></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.1. <b><u>Reservation
of Authorized and Unissued Shares</u></b>. The Company covenants that, during the period the Warrant is outstanding, it will <font style="font-family: Times New Roman, Times, Serif">reserv</font>e
from its authorized and unissued Ordinary Shares a sufficient number of Ordinary Shares to provide for the issuance of the Warrant Shares
upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute
full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may
be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Ordinary Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means that no further sums are
required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.2. <b><u>Noncircumvention</u></b>.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.3. <b><u>Authorizations,
Exemptions and Consents</u></b>. Before taking any action that would result in an adjustment in the number of Warrant Shares for which
this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.5. <b><u>Governing
Law</u></b>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding the foregoing, nothing
in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under the federal securities
laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.6. <b><u>Restrictions</u></b>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.7. <b><u>Nonwaiver
and Expenses</u></b>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. No provision of this Warrant shall be construed as a waiver by the Holder
of any rights which the Holder may have under the federal securities laws and the rules and regulations of the Commission thereunder.
Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.8. <b><u>Notices</u></b>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 61 Robinson Road Level 6 &amp; 7, #738, Singapore 068893, Attention: Siguang Peng, Chief Executive Officer, email address:
[&#9679;], or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices
or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail,
or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder
appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on
the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth
in this Section 5.8 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section 5.8 on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be
given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.9. <b><u>Limitation
of Liability</u></b>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the purchase price of any Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by
creditors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.10. <b><u>Remedies</u></b>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.11. <b><u>Successors
and Assigns</u></b>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.12. <b><u>Amendment</u></b>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
a majority-in-interest of Holders of the Warrants, on the other hand. No modification or amendment or modification of the provisions hereof
may be waived in a manner that is more favorable to other holder(s) of Warrants, as applicable, or to treat any holder(s) of Warrants
in a manner that is in any respect not equal to the treatment of all other holder(s) of Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.13. <b><u>Severability</u></b>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.14. <b><u>Headings</u></b>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>[BTCT Investor Registered Pre-Funded Warrant
Signature Page Follows]</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>[BTCT Investor Registered Pre-Funded Warrant
Signature Page]</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Registered Pre-Funded Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td colspan="2">BTC DIGITAL LTD.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td colspan="2">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>By:</td>
  <td style="border-bottom: Black 1.5pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 60%">&nbsp;</td>
  <td style="width: 5%">Name:&nbsp;</td>
  <td style="width: 35%">Siguang Peng</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>Its:</td>
  <td>Chief Executive Officer</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><u>Exhibit 2.1</u></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF EXERCISE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font style="text-transform: uppercase">To:</font></td><td style="text-align: justify">BTC DIGITAL LTD.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 1in">&nbsp;</td>
  <td style="width: 0.5in">&#9744;</td>
  <td>in lawful money
of the United States.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
  <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>&#9744;</td>
  <td style="text-align: justify">if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2.3, to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2.3.</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 1in">&nbsp;</td>
  <td style="border-bottom: Black 1.5pt solid; width: 2.5in">&nbsp;</td>
  <td>&nbsp;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 1in">&nbsp;</td>
  <td style="border-bottom: Black 1.5pt solid; width: 2.5in">&nbsp;</td>
  <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
  <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td style="border-bottom: Black 1.5pt solid">&nbsp;</td>
  <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
  <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&nbsp;</td>
  <td style="border-bottom: Black 1.5pt solid">&nbsp;</td>
  <td>&nbsp;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase">[SIGNATURE
OF HOLDER]</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 45%; text-align: left">Name of Investing Entity: </td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 55%; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">&nbsp;</td>
    <td style="vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: bottom; text-align: left"><i>Signature of Authorized Signatory of Investing Entity</i>:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">&nbsp;</td>
    <td style="vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">Name of Authorized Signatory: </td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">&nbsp;</td>
    <td style="vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">Title of Authorized Signatory: </td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">&nbsp;</td>
    <td style="vertical-align: top; text-align: justify">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: left">Date: </td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: justify">&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><u>Exhibit 2.4.6</u></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ASSIGNMENT FORM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase Ordinary Shares.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 20%">Name:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 40%">&nbsp;</td>
    <td style="width: 40%">&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Address:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Phone Number:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Email Address: </td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Date:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Holder&rsquo;s Signature:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr>
    <td style="vertical-align: bottom">Holder&rsquo;s Address:</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>
<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea022404301ex5-1_btcdigi.htm
<DESCRIPTION>OPINION OF CONYERS DILL & PEARMAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%; padding-right: 2.25pt; font-size: 10pt; font-weight: bold"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 30%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">CONYERS DILL &amp; PEARMAN</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">29<SUP>th</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">One Exchange Square</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">8 Connaught Place</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Central</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Hong Kong</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">T +852 2524 7106 | F +852 2845 9268</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt">conyers.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">9 December 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">Matter No. 1004762</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">(852) 2842 9580</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">Ryan.McConvey@conyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>BTC Digital Ltd. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">61 Robinson Road Level 6 &amp; 7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">#738, Singapore 068893</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Re: BTC Digital Ltd. (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We have acted as special Cayman Islands
legal counsel to the Company in connection with a public offering (the &ldquo;<B>Offering</B>&rdquo;) in the United States of an aggregate
of (i) 880,000 ordinary shares, par value US$0.06 each of the Company (the &ldquo;<B>Closing Shares</B>&rdquo;); (ii) 1,620,000 pre-funded
warrants (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo; and each a &ldquo;<B>Pre-Funded Warrant</B>&rdquo;) to purchase 1,620,000 ordinary
shares, par value US$0.06 each of the Company exercisable at an exercise price of US$0.001 per share (the &ldquo;<B>Warrant Shares</B>&rdquo;);
and (iii) up to 375,000 additional ordinary shares, par value US$0.06 each of the Company at the option of the Underwriter (as defined
below) (the &ldquo;<B>Option Shares</B>&rdquo; and together with the Closing Shares, the &ldquo;<B>Offer Shares</B>&rdquo;) each as described
in the Registration Statement and the Prospectus (both as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify; padding-right: 0.25in"><B>DOCUMENTS REVIEWED</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For the purposes of giving this opinion,
we have examined copies of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">the Company&rsquo;s registration statement on Form S-3 (File No. 333-283367) (the
&ldquo;<B>Form S-3</B>&rdquo;) filed with the Securities and Exchange Commission in the United States (&ldquo;<B>SEC</B>&rdquo;) on 20
November 2024 and declared effective by the SEC on 5 December 2024 (the &ldquo;<B>Registration Statement</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">the Company&rsquo;s prospectus included in the Registration Statement dated 20
November 2024 (the &ldquo;<B>Base Prospectus</B>&rdquo;) and the prospectus supplement dated 9 December 2024 (the &ldquo;<B>Prospectus
Supplement</B>&rdquo;, together with the Base Prospectus, the &ldquo;<B>Prospectus</B>&rdquo;) relating to the Offering of the Offer Shares
and the Pre-Funded Warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">the underwriting agreement made among Aegis Capital Corp. (the &ldquo;<B>Underwriter</B>&rdquo;)
and the Company dated 6 December 2024, as amended by the first amendment to the underwriting agreement made among the Underwriter and
the Company dated 9 December 2024 (collectively, the &ldquo;<B>Underwriting Agreement</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">the Pre-Funded Warrants issued by the Company to certain investors each dated 9
December 2024;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.5</TD><TD STYLE="text-align: justify">a copy of the amended and restated memorandum and articles of association of the
Company certified by the secretary of the Company on 9 December 2024 (the &ldquo;<B>Memorandum and Articles of Association</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.6</TD><TD STYLE="text-align: justify">copies of written resolutions of the directors dated 20 November 2024 and written
resolutions of directors dated 5 December 2024 (the &ldquo;<B>Resolutions</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.7</TD><TD STYLE="text-align: justify">a Certificate of Good Standing issued by the Registrar of Companies in relation
to the Company on 5 December 2024 (the &ldquo;<B>Certificate Date</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.8</TD><TD STYLE="text-align: justify">a certificate issued by a director of the Company on 5 December 2024 (the &ldquo;<B>Director
Certificate</B>&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.9</TD><TD STYLE="text-align: justify">such other documents and made such enquiries as to questions of law as we have
deemed necessary in order to render the opinion set forth below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>ASSUMPTIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We have assumed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">the genuineness and authenticity of all signatures and the conformity to the originals
of all copies (whether or not certified) examined by us and the authenticity and completeness of the originals from which such copies
were taken;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">that where a document has been examined by us in draft form, it will be or has
been executed and/or filed in the form of that draft, and where a number of drafts of a document have been examined by us all changes
thereto have been marked or otherwise drawn to our attention;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify">the accuracy and completeness of all factual representations made in the Underwriting
Agreement, the Pre-Funded Warrants, the Registration Statement, the Prospectus and other documents reviewed by us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify">that the Resolutions were passed at one or more duly convened, constituted and
quorate meetings or by unanimous written resolutions, remain in full force and effect and have not been rescinded or amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.5</TD><TD STYLE="text-align: justify">the issuance and sale of the Offer Shares by the Company, and the Company&rsquo;s
incurrence and performance of its obligations under the Underwriting Agreement and the Pre-Funded Warrants in accordance with the terms
thereof will not violate the Memorandum and Articles of Association nor any applicable law, regulation, order or decree in the Cayman
Islands;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify">that the issuance and sale of and payment for the Offer Shares will be in accordance
with the Underwriting Agreement, the Registration Statement and the Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.7</TD><TD STYLE="text-align: justify">that, upon the issue of the Offer Shares or the Warrant Shares, the Company will
receive consideration for the full issue price thereof which shall be equal to at least the par value thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.8</TD><TD STYLE="text-align: justify">the capacity, power and authority of each of the parties to the Underwriting Agreement
and the Pre-Funded Warrants other than the Company, to enter into and perform its respective obligations under the Underwriting Agreement
and the Pre-Funded Warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.9</TD><TD STYLE="text-align: justify">that there is no provision of the law of any jurisdiction, other than the Cayman
Islands, which would have any implication in relation to the opinions expressed herein;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.10</TD><TD STYLE="text-align: justify">that the Company will have sufficient authorised and unissued share capital to
effect the issue of the Warrant Shares and the Option Shares at the time of issuance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.11</TD><TD STYLE="text-align: justify">the validity and binding effect under the laws of the United States of America
of the Registration Statement and that the Registration Statement will be duly filed with the Commission;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.12</TD><TD STYLE="text-align: justify">there is no contractual or other prohibition or restriction (other than as arising
under Cayman Islands law) binding on the Company prohibiting or restricting it from entering into and performing its obligations under
the Registration Statement and the Underwriting Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.13</TD><TD STYLE="text-align: justify">that the Registration Statement has been declared effective by the Commission prior
to, or concurrent with, the sale of the Securities pursuant to the Registration Statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.14</TD><TD STYLE="text-align: justify">that the Offering and the transactions contemplated thereunder comply with the
requirements of the applicable rules of The Nasdaq Stock Market LLC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify; padding-right: 0.25in"><B>QUALIFICATIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">We have made no investigation of and express no opinion in relation to the laws
of any jurisdiction other than the Cayman Islands. This opinion is to be governed by and construed in accordance with the laws of the
Cayman Islands and is limited to and is given on the basis of the current law and practice in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify; padding-right: 0.25in"><B>OPINIONS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">On the basis of and subject to the
foregoing, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Company is duly incorporated and existing under the law of the Cayman Islands
and, based on the Certificate of Good Standing, is in good standing as at the Certificate Date. Pursuant to the Companies Act (the &ldquo;<B>Act</B>&rdquo;),
a company is deemed to be in good standing if all fees and penalties under the Act have been paid and the Registrar of Companies has no
knowledge that the Company is in default under the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The Company has taken all corporate action required to authorise the issuance,
sale and offer of the Offer Shares, the Pre-Funded Warrants and the Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">When issued and paid for as contemplated in the Underwriting Agreement, the Registration
Statement and the Prospectus and registered in the register of members of the Company, the Offer Shares will be validly issued, fully
paid and non-assessable (which term when used herein means that no further sums are required to be paid by the holders thereof in connection
with the issue thereof).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">When issued, executed, delivered and paid for as contemplated in Underwriting Agreement,
the Registration Statement and the Prospectus, the Pre-Funded Warrants will be validly issued and constitute the legal, valid and binding
obligations of the Company in accordance with the terms thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">When issued and paid for as contemplated in the Pre-Funded Warrants, the Registration
Statement and the Prospectus and registered in the register of members of the Company, the Warrant Shares will be validly issued, fully
paid and non-assessable (which term when used herein means that no further sums are required to be paid by the holders thereof in connection
with the issue thereof)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">We hereby consent
to the filing of this opinion as an exhibit to the Company&rsquo;s report filing on Form 8-K with the Commission, which will be incorporated
by reference into and deemed part of the Registration Statement and to the references to our firm under the caption &ldquo;Legal Matters&rdquo;
in the Prospectus forming a part of the Registration Statement. In giving such consent, we do not hereby admit that we are experts within
the meaning of Section 11 of the Securities Act or that we are in the category of persons whose consent is required under Section 7 of
the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><I>/s/ Conyers Dill &amp; Pearman</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Conyers Dill &amp; Pearman</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com |&nbsp;4</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ea022404301ex99-1_btcdigi.htm
<DESCRIPTION>AMENDMENT TO THE UNDERWRITING AGREEMENT, DATED DECEMBER 9, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FIRST AMENDMENT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS FIRST AMENDMENT (<B><I>&ldquo;First Amendment&rdquo;</I></B>)
to the Underwriting Agreement dated December 6, 2024 (the <B><I>&ldquo;Underwriting Agreement&rdquo;</I></B>) is made as of the 9th day
of December, 2024, by and between BTC Digital Ltd. and Aegis Capital Corp. Capitalized terms used herein and not otherwise defined shall
have the meanings ascribed to them in the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the parties hereto desire to amend and
restate Schedules 1.18 and 4.1.2 of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. Schedule
1.18 and Schedule 4.1.2 are hereby amended and restated as set forth on the attached schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. Except
as expressly amended hereby, the Underwriting Agreement shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3. This
First Amendment may be executed in counterparts, each of which will be deemed an original, but all of which together will be deemed to
be one and the same agreement. Counterparts may be delivered via facsimile, email (including PDF or any electronic signature complying
with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method, and any counterpart so delivered will be
deemed to have been duly and validly delivered and be valid and effective for all purposes..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[BTCT Underwriting Agreement Amendment Signature
Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt">If the foregoing is in accordance with your understanding,
please indicate your acceptance of this First Amendment by signing in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BTC DIGITAL LTD.</B></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%; font-size: 10pt">/s/ Siguang Peng</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Name:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Siguang Peng</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Title:</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Confirmed and accepted as of the date first above written:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AEGIS CAPITAL CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom; font-size: 10pt; width: 35%">/s/ Robert Eide</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">Robert Eide</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 1.18</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pricing Disclosure Package </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%">Number of Closing Shares:</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">880,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Number of Closing Pre-funded Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,620,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Number of Option Shares:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Number of Option Pre-funded Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Public Offering Price per Closing Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Public Offering Price per Closing Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercise Price per Pre-Funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Underwriting Discount per Common Share and per Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-accountable expense allowance per Common Share and per Pre-funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.060</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Purchase Price per Option Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Purchase Price per Option Pre-Funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7.379</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 4.1.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Closing Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold">Underwriter</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number of<BR> Closing Shares to<BR> Be&nbsp;Purchased</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number of<BR>
 Closing Pre-<BR>
funded Warrants <BR>
to Be Purchased</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number of<BR>
 Option Shares to <BR>
Be Purchased if <BR>
the Maximum <BR>
Over-Allotment <BR>
Option Is<BR>
 Exercised</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-bottom: 1.5pt">Aegis Capital Corp.</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">880,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,620,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">375,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">4</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="text-align: center; font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ea022404301ex99-2_btcdigi.htm
<DESCRIPTION>PRESS RELEASE, DATED DECEMBER 5, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>BTC Digital Ltd. Announces Launch of Proposed
Underwritten Public Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SINGAPORE, DECEMBER 5, 2024 (GLOBE NEWSWIRE)</B>
-- BTC Digital Ltd. (NASDAQ: BTCT) (the &ldquo;Company&rdquo;), a blockchain technology company, today announced that it has commenced
a public offering to offer and sell Ordinary Shares (or pre-funded warrants in lieu thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to use the net proceeds from
this Offering for general corporate and working capital needs. The Company&rsquo;s Ordinary Shares are trading on the Nasdaq Capital Market
under the symbol &ldquo;BTCT&rdquo;. The Offering is subject to market conditions, and there can be no assurance as to whether or when
the Offering may be completed, or as to the actual size or terms of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company expects to grant Aegis
Capital Corp. a 45-day option to purchase additional Ordinary Shares of up to 15% of the number of Ordinary Shares sold in the Offering
solely to cover over-allotments, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Aegis Capital Corp. is acting as the sole book-running
manager for the offering on a firm commitment basis. VCL Law LLP and Conyers Dill &amp; Pearman are acting as counsel to the Company.
Kaufman &amp; Canoles, P.C. is acting as counsel to Aegis Capital Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering is being made pursuant to an effective
shelf registration statement on Form S-3 (No. 333-283367) previously filed with the U.S. Securities and Exchange Commission (SEC) and
declared effective by the SEC on December 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the
proposed offering will be filed with the SEC and will be available on the SEC&rsquo;s website located at <U>www.sec.gov</U>. Electronic
copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital
Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com,
or by telephone at +1 (212) 813-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About BTC Digital Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">BTC Digital Ltd.is a
blockchain technology company, with a long-term strategy to create value across the metaverse, blockchain and cryptocurrency mining industry.
The Company is committed to developing blockchain related businesses in North America, including cryptocurrency mining, mining farm construction,
mining pool and data center operation, and miner accessories business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing material may contain &ldquo;forward-looking
statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,
each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including
without limitation statements regarding the Company&rsquo;s product development and business prospects, and can be identified by the use
of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;should,&rdquo; &ldquo;continue&rdquo; or the negative versions
of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking
statements are based on information currently available to the Company and its current plans or expectations and are subject to a number
of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize,
or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected,
intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable,
the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information, please visit: https://btct.investorroom.com/</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>7
<FILENAME>ea022404301ex99-3_btcdigi.htm
<DESCRIPTION>PRESS RELEASE, DATED DECEMBER 6, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BTC Digital Ltd. Announces Pricing of $20.0
Million Underwritten Public Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SINGAPORE, DECEMBER 6 2024 (PR NEWSWIRE)</B>
-- BTC Digital Ltd. (NASDAQ: BTCT) (the &ldquo;Company&rdquo;), a blockchain technology company, today announced the pricing of a firm
commitment underwritten public offering with gross proceeds to the Company expected to be approximately $20.0 million, before deducting
underwriting fees and other estimated offering expenses payable by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering consists of 2,500,000 Ordinary Shares
and Pre-Funded Warrants. The public offering price per Common Share is $8.00 (or $7.999 for each Pre-Funded Warrant, which is equal to
the public offering price per Ordinary Share to be sold in the offering minus an exercise price of $0.001 per Pre-Funded Warrant). The
Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant
sold in the offering, the number of Ordinary Shares in the offering will be decreased on a one-for-one basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company has granted Aegis Capital
Corp. (&ldquo;Aegis&rdquo;) a 45-day option to purchase additional Ordinary Shares of up to 15.0% of the number of Ordinary Shares sold
in the offering solely to cover over-allotments, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aggregate gross proceeds to the Company are expected
to be approximately $20.0 million. The transaction is expected to close on or about December 9, 2024, subject to the satisfaction of customary
closing conditions. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate
purposes and working capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Aegis Capital Corp. is acting as the sole book-running
manager for the offering.VCL Law LLP is acting as U.S. counsel to the Company. Kaufman &amp; Canoles, P.C. is act as U.S. counsel to Aegis
Capital Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering is being made pursuant to an effective
shelf registration statement on Form S-3 (No. 333-283367) previously filed with the U.S. Securities and Exchange Commission (SEC) and
declared effective by the SEC on December 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the
proposed offering will be filed with the SEC and will be available on the SEC&rsquo;s website located at www.sec.gov. Electronic copies of the
final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention:
Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone
at +1 (212) 813-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interested parties should read in their entirety
the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated
by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such
an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About BTC Digital Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">BTC Digital Ltd.is a
blockchain technology company, with a long-term strategy to create value across the metaverse, blockchain and&nbsp;cryptocurrency&nbsp;mining
industry. The Company is committed to developing blockchain related businesses in&nbsp;North America, including&nbsp;cryptocurrency&nbsp;mining,
mining farm construction, mining pool and data center operation, and miner accessories business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing material may contain &ldquo;forward-looking
statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,
each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including
without limitation statements regarding the Company&rsquo;s product development and business prospects, and can be identified by the use of
words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;should,&rdquo; &ldquo;continue&rdquo; or the negative versions of those
words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking
statements are based on information currently available to the Company and its current plans or expectations and are subject to a number
of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize,
or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected,
intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable,
the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information, please visit: https://btct.investorroom.com/</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>8
<FILENAME>ea022404301ex99-4_btcdigi.htm
<DESCRIPTION>PRESS RELEASE, DATED DECEMBER 9, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BTC Digital Ltd. Announces Closing of $20.0
Million Underwritten Public Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SINGAPORE, DECEMBER 9, 2024 (GLOBE NEWSWIRE)</B>
&mdash; BTC Digital Ltd. (NASDAQ: BTCT) (the &ldquo;Company&rdquo;), a blockchain technology company, today announced the closing of its
previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before
deducting underwriting fees and other estimated offering expenses payable by the Company. The offering closed on December 9, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering consisted of 2,500,000 Ordinary Shares
and Pre-Funded Warrants. The public offering price per Common Share is $8.00 (or $7.999 for each Pre-Funded Warrant, which is equal to
the public offering price per Ordinary Share to be sold in the offering minus an exercise price of $0.001 per Pre-Funded Warrant). The
Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant
sold in the offering, the number of Ordinary Shares in the offering will be decreased on a one-for-one basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company granted Aegis Capital
Corp. (&ldquo;Aegis&rdquo;) a 45-day option to purchase additional Ordinary Shares of up to 15.0% of the number of Ordinary Shares sold
in the offering solely to cover over-allotments, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Aegis Capital Corp. acted as the sole book-running
manager for the offering. VCL Law LLP acted as U.S. counsel to the Company. Kaufman &amp; Canoles, P.C. acted as U.S. counsel to Aegis
Capital Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering was made pursuant to an effective
shelf registration statement on Form S-3 (No. 333-283367) previously filed with the U.S. Securities and Exchange Commission (SEC) and
declared effective by the SEC on December 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the
proposed offering will be filed with the SEC and will be available on the SEC&rsquo;s website located at <U>www.sec.gov</U>. Electronic
copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital
Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com,
or by telephone at +1 (212) 813-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such
an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About BTC Digital Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BTC Digital Ltd.is a blockchain technology company,
with a long-term strategy to create value across the metaverse, blockchain and cryptocurrency mining industry. The Company is committed
to developing blockchain related businesses in North America, including cryptocurrency mining, mining farm construction, mining pool and
data center operation, and miner accessories business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing material may contain &ldquo;forward-looking
statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934,
each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including
without limitation statements regarding the Company&rsquo;s product development and business prospects, and can be identified by the use
of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;should,&rdquo; &ldquo;continue&rdquo; or the negative versions
of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking
statements are based on information currently available to the Company and its current plans or expectations and are subject to a number
of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize,
or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected,
intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable,
the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information, please visit: https://btct.investorroom.com/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>btct-20241205.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaaB2aPtyJ1xSYkxuG98ffn6fyQrfPurEinFfPVmkXAG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BTCT="http://btct.investorroom.com/20241205" elementFormDefault="qualified" targetNamespace="http://btct.investorroom.com/20241205">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://btct.investorroom.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="btct-20241205_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="btct-20241205_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="btct-20241205_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="BTCT_OrdinarySharesMember" name="OrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BTCT_WarrantsMember" name="WarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>btct-20241205_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://btct.investorroom.com/role/Cover" xlink:href="btct-20241205.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://btct.investorroom.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_OrdinarySharesMember" xlink:label="loc_BTCTOrdinarySharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BTCTOrdinarySharesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_WarrantsMember" xlink:label="loc_BTCTWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BTCTWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>btct-20241205_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_OrdinarySharesMember" xlink:label="BTCT_OrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BTCT_OrdinarySharesMember" xlink:to="BTCT_OrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BTCT_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_WarrantsMember" xlink:label="BTCT_WarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BTCT_WarrantsMember" xlink:to="BTCT_WarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BTCT_WarrantsMember_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>btct-20241205_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://btct.investorroom.com/role/Cover" xlink:href="btct-20241205.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://btct.investorroom.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_OrdinarySharesMember" xlink:label="loc_BTCTOrdinarySharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BTCTOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="btct-20241205.xsd#BTCT_WarrantsMember" xlink:label="loc_BTCTWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BTCTWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G 0P# 2(  A$! Q$!_\0
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M.[!9EB9937Q69THX>6'=2G4JQ2BIRI.5.=2#7V92IRE&ST4H^:/SS_X*J?\
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M598+73="\/Z%I\VHZKK%W-*%S9VMM#G$23S27,GE1HX_=I_+?_P3?_X*0_\
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M'UV'3M3T_P 0:9#J=C:ZC;V.M:=*UUIVKV27$4D,&HVD\CRV]_;QQS(S;D<
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M>&/%VIZQJ.I^*?A5KNJ:JL;6-E>ZG<W>O>"_%>I2)HEY;WT>CQZGY*Z>MO\
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6YZCES5)VC%^_-KFD[ZN[=W=O5G__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45789690806192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  05,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BTC DIGITAL LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001796514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">61 Robinson Road Level 6 & 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">#738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">SG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">068893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6022 2515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BTCT_OrdinarySharesMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTCT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BTCT_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTCTW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BTCT_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BTCT_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BTCT_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BTCT_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MK844,Y,DZW1G;J82BQ:JF^=!.0D"VL"G*I:AM#)=LB]H9%J*N)*'5JGE*4=
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( ,N(B5GO!#AD[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,N(B5F97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ RXB)
M66#V>%N.!   8A,  !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( ,N(B5G@]#J)J@(  # ,   -
M      "  =$,  !X;"]S='EL97,N>&UL4$L! A0#%     @ RXB)69>*NQS
M    $P(   L              ( !I@\  %]R96QS+RYR96QS4$L! A0#%
M  @ RXB)6:K$(A8S 0  (@(   \              ( !CQ   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( ,N(B5DD'INBK0   /@!   :
M  "  >\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M ,N(B5EED'F2&0$  ,\#   3              "  =02  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  !X4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0224043-8k_btcdigi.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://btct.investorroom.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>btct-20241205.xsd</File>
    <File>btct-20241205_def.xml</File>
    <File>btct-20241205_lab.xml</File>
    <File>btct-20241205_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0224043-8k_btcdigi.htm">ea0224043-8k_btcdigi.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0224043-8k_btcdigi.htm": {
   "nsprefix": "BTCT",
   "nsuri": "http://btct.investorroom.com/20241205",
   "dts": {
    "schema": {
     "local": [
      "btct-20241205.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "btct-20241205_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "btct-20241205_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btct-20241205_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0224043-8k_btcdigi.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://btct.investorroom.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0224043-8k_btcdigi.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0224043-8k_btcdigi.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "BTCT_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://btct.investorroom.com/20241205",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "BTCT_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://btct.investorroom.com/20241205",
     "localname": "WarrantsMember",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://btct.investorroom.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001213900-24-107009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-107009-xbrl.zip
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MXO0CN:>L"Y^VS#4U-I,Z+$U-4(Q8C(%HE%I4BCT1\:\M9@5AZ5,O%(;2-1>
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M5 2! FC+6,FE%B*E= S!#2,"0L(3(1\"%.L7LNO5RCK:=XE=0=%O6,$!*X.
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MAYF2J0_?9H<R&+54"55VA#T_1^=M.S\=V9<:P'Q'B\S=PS4,?R?\30(&+4C
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MJ7\R1KT22AJWA@RY1!N?YZ#Q>7[D^(Q;2_K<(4$NYL[;8^Q^RMF<^-?G!1N
MURJU GW \ZF71^;+IMRC?U2:QW%G7]3S]TBAY)&7HH9\GIIYEC!#DR*D.R:(
MB&V-MK7AN0#0W J:">2UJD#W*/<=OE#.?Q'R18PIT5+0I"@90K<>O$V@Z6C#
M?<\&WRBY^"QY9G&I?#:L\AP5'BF4?1ON=WI\XDQ +>9Z;[^?BN? A=#[6D S
MT(8;GV'72%/R#'5/TF+/]!TQ9!-A*!&^%M!$M.$F:-@UVD(#-;0.YC)\Y_]
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M@7G4Y.MMKV+0[O+)?KKYQ/UP_Z. ?>=W4$L#!!0    ( ,N(B5GTLF$.MQT
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M('>X)CR -]1*.##P\D-*G6CP@'I]/JU\L#C8M4WFI8[F3Q+#==_-^S.'>>F
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MFV>GG5ZGW26-HQ9I7S0_-HX^M$GS^//G3K?;.3YZ.=C.J3<RK*%OPZRM0K-
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M=PO#5QV\O92'C//YM /:EU]5Y^;KM?7/F=JX.R7]J./NR9TK45U?Q"^[%\Y
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MR&@F05<L.0@]2W>H"M_#!+R.VJ6Z0T1&V=O&I63K^0[Y&XL(WZ^T*="VL''
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MXTG9M-];Q<I$Z]4/*J/JR+^:?&S\(ZA:[-OZ#/^%$-[<^W]02P,$%     @
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M,=4*Q'0NK@Q]XFR%%S<BFX?XKE0%"QH\>K=\4#]UNFD1 TV!J'+W M8-ZZ*
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M=%W$-8-13\F@+GR3CF8)G1<8SAFG*7Y-Q5E%3J%JUU,9Q$[5NWUXWM/7<IG
M1HY2\HOAMRA%8Y+G2C%V>B(L\ _;P%RA](>\N 8&N4@13_$2/"6P'QQ&VQYP
MH39J7P"YWO?S<1RD.D #CM(QUJ^;_-PDFUBE*JH; 6)ZCZ>FX_Q1=Y<-!WKJ
MB8_<33$(+N[2LR_:I+ZCS]#>%'KY3/7]. *!KHV;*,&C%HP//JSB=E.K6/&E
MJE8%RT_[#01_Q[R</[#B;C+"!+)1I>5"BILXF8]Y,NHVS,@-\FFS9KF!5=O3
M99EGU:6 +09]D+DK'>ZH D@_XD=5T@^)HFX]SM5!6#FUB84(,Y6J?;ABIETA
MM%%X-E_IWL$-U.XZVUB!UW5+6U#87TG<TMG#FTFA5G513+R1//%\10W >':P
M%<9OKMO KEVB]OVJ=J<Q3*9JY9T)*3\ZNJL=ZP>V7JH#R=6\9SCH3^5^OVIQ
M%H8W12!3/O19@MNWUBC81<JNE^#\I-I;7+RQ,97BSC(RM=#&1_%+OZ(SC\Z!
M$Z(BF2IO7-Z00$K7WJX/39_M0],2FC[;AZ;_1'+CKC/D G!)B9"4<P]B "(
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MTZ)=Q$4B+3[G(K793PDSP;=! 3>DH#,.S>74G.UAD_KNC/C&6*<-4''S/$&
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M8FMG%ODNUJ 8BDUZ,2E^8QY^([>JV?_5JW^X^$>+/\)^CZTZ/3"OFLUF/Q(
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MOG\CA%?U3+2YG6MX=F/WK5*ZLDTN[".EN]J0I!T7MKH+SE!"ZY1WSA<ICI_
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M^<^[?YW4'S+%S/)$OYG?\-L54@Y]@F59+1/I-^5(C^$Z3R$+_+TKHE&;KOL
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M!:ED:A/(]IMO^Q$.$',XL!TN7]W;E)[+B4?=,">=ZM+K<BD3JQD!JW=41&=
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MHD4Q2Z,#%I'%B.SC]&,Z7S#T*?5SR2WBYNI-\./AAC(];_=67DC"94B#"$B
M^(/7E<,]M^5\G6$:3C:UM;'WLI1<QC'HIER05=B2= BHD^5+"1 %)8M5+'3A
MF]D4,71$JE)G$X:!9@7:?!727] =U('M5T"/(^ ="D1@:@$9Q@63E%\")%3W
M:%@W*CO==LK1X;$'EAT.P%]9%*6KSV:O%DO6I90=+^:P&7Z!V40IP&QM&^8K
M2MP"R=OA:CP$8&-=6*(BZ_(1$79)+U+P').9VI5T=5I>"4H^^7K5FE6X"(9&
M(8$GTMF4S(#DHS1'Y)SO;-\-&Y\YC\^OOBKT<7_96O5NV?70V'H)M4::B-(:
MV46Y5-G)8%H;CCZAN9S$3ZOHLIA-*#(K8*(AV)JK4%G0#$P.A>*D%EV+SP33
MF:A@?ZMIEE8:^;G**CJ$P#D:BCXY.4@.UUAPY+J?W'O8Z[KS.$ARW@0&BZP\
M-P#CY#2:PQ9=HN0&\G,_J0-;%!Q4U^Q(V*R"=QK8A,"D&Y=RN*&!)! =N%U1
M2W30=L'IG"#6(YU-FN$DX;=TPD?,T'G[#70 +!+0YY,E'>!Y(XKB!/&S&1"F
M+/)LC%4;2?1+@L>0@K#GX!JN<+05ST,'>9E>@:2H5J"4YM%! #'[[.DOYV];
M>+*WV\*^ATU.>IY_DYDH;[CBO<=98\V"B0B9Q)O66B-O6KX[QN")\HJ#WW6-
MP*/D#EX4XM"JQ\6!Q$E:C4$[PGW^*(P3OD&V_3?NJM+/T2,ES]FM"7@X<.D<
M8>MU:*2WG:FX-42G18)L'@Y^3<H/:;UO"/ H8,?<$?"<X#-$;R"_@GI(08P>
M/#H^!%6PJHRJ"&K;VHCIK9!">RI>2]"C68-))[+6X^%@08TQ,0'AQF3EHJ)E
MFPM_0P"YU-FS4.O*7J2U)K$?\M=_,3_Q@N8'^ZO >L9:&"J<ELF$X9/5."5#
MS(%H<RJ#&]2GF$,IX5C.R'0%VLM//O/166T:V.U>Q0T'O9K?X%EPS^3K<L)]
ME8II++VZ_C:@ $'A,H@W@PS+V!(>\H<_PJ?F%RF/LX5?Z%-U%ES,3?B(ZCQ;
MT33Q62%0983^K-.B&/\Y%X3CF,0R;(WL,=,KTZWA%&2LB44*5_ *Z0NNDX4C
M/4YN42QH-B!D&ZK8#5%CRLO$--/:F@(!BCDH<[+G.49!]EAQ#8*]NLP6#H>\
MAY8.QA[,/4=7G!R1<B9.KZ%%\:ATHR\PZ3-+T#DDOI<LZ@A,.#1&.*!8I74]
M8Z0].Z2V8T'X(F!5>K%=#+XEJ2X#9O7Y!S9&,1BI8[_4N;E!N-(WH<N,U[!5
M(/!L'PC40.#9/A#X)^%LL@-.CWC"&(@4\& DY"6(S2RP?-44F@U2.&6"/&*.
M%S]R8MY%BF)*OW7I)1HWJL:S2Y;P9-L7.;(HNJ)O9DE.8NY:C7.Y+VSS;68S
MO;#%C.*RIFD%J"4WV][87-%?2K79]H8O?G)HK D[R#N!KP GA0P.]^V)LX?0
M$G#C5AM$B,@/-RID=Q=BIZ\ 0TSC>QS'()_;&Q&X0MD*6)E8@<H_Z*.[2]=&
M$L[..$D[ANW%S%M@  %#HB$F<Q,D6$>&1UIB/3TC9W493(WA)"YC+=J5'7YG
MOE![@<Q(-E$0RAFS(]B1*WO*;&[J4Z:MK8R^Q$Y^ 89\QFN5$J_N#OD>0L(/
MX"#,@2GO/"3[!SD!XYU%R<#OFM:VP&K;T>%;$H$SH<\/NRRHINVD?&UJ>\#<
M' /W53)(&<TN7">L=VR-O"HZ4!L0B(P)8;1YT;)"Q2V1?.>78,D//+1>A;]+
M*C#^*(1?E!=)GOVA$7&Q\M"0.PSP]K'?Y'>!?'&Y8S3#\3S")>Q\%&5S D4<
M[7#&AX.O<\BC]6?<\"TB/7S"D3>U'ZUCS!#*(16<]>XP=Z3?*)^M: H1,3C<
M7V&!L$_G\UYJ\)&D 5_DB\UB#?V;L2X4NER.JFR2)259[G T)/$#RQ[K*2WI
M]^BA""&84;C&;:1#LJI5CF4(\(UC[V&ZOX;;SZDQ^C:A0&N"LF];&Z4Y;*O4
MU,FO730U X>RJE4*TF"SN#$/S_5,!4Y1,,Q0WYKQ"<2O-\P(W@I8.QF6!4E^
M2D P*&18)AD%)L;)(A-()'(;-7\$#F&5RC-6GB#X*EJ[V ;^?:TX=8R_N"RN
MTRO&[(Y#;AD.=I L\">U 6P!(7N%%9I,:D6PT%K'PD&F#?Q1<+!U/!<3B28O
MS2GZA=UJV4P"X(M,<VT]]2"W)K%D+.&[BI'1JLC#07YX5#&P@/&.,F5QKJ.=
M2 .F"<,37B<ZLCPPJ8.14L@Y+XOQASN_+<+!5E8O@MY5=,.C1U9858U(&CS3
M#^ZF,SE7@*_FNDJ2-[#;,@E+.(6T.=PLR0HNJ(N$*B<:R1L.M(S-35>G4L6#
MNX?!J+[*3J</4TNZPM:Z2-/GH01RU$WRO%BB- X^#GV6YM>11ER4N!#]X^X?
M?*H?',GWNC%<K&RC/+VN7!HXP>F%G;/F/Y46^Z +'TCJL'A5U,CAZL7QZ42*
M$N /L@T(<NNB=GBF5*-'-1!4>(F*_5;36"A\8F=44)YV!-:6LSFC7\$"72"T
M8#!$ZU61M[&K4#RZ 74N6+I@0PD5/MIP+$45F9">D"&&/>S7%*PI4I@X ;1#
M MM)W'GA1J2A$K] C-Y#3BC4R8>T/_S.X_DT(LOUU3IG+ZG)5@>#82D?@+_#
MPA2L'C&5/B/2G^F8(9S!Z%CRT95V<Y$O59.6<T-+WPN2>0Q66Y@4$%?B,YWS
M!7N'"J;Y!?7C8@B\JE#BB!4P3SZ0.6$=%UESRXCA7S^3?$#86"##8]XR]B1^
MU*^W.*\F!\H,?7GAS&*_=>?CGB(5:RKC;8TTTU*R*R[337AW5ZU(V-H,N,_>
M;$J!=XY(SF0R4.*::2JIK%*_+8@KN#/>=''(;W#E?EC7Y5+FQI,0SZ?'L\0W
M>?I&AKR')B'??<4-8M(-*85[^Y2"IA3N[5,*?PX!:! 9WTM2=C@XOPBJ\YZK
M"^^*#M!N7J5):4IXO'UL1_^&)02"^,*:#MVC>9)1VL(U9;N&;)]<+WG$I<O<
M)Q?:)]FA F^0L/A.&VJ:G-_R3#BWD</!%]O)#2VV 3H8_&U%T4E7Q1FCE:9-
M6UR7S=/K7!1F;!&AJ^@ - G8,!G'BNB20U-BB$6'/I+7P18Z?,V]DP*3]$X=
MH*K/-Z@MP0ND$J2[@U.T9YY(_,V8AEJ<0=<L060E&.T#)5E+2)2*#Q\#OWR9
M2DLW"+#OJSH:HH,R2[+E><.^5JGE_I2:[M6W4KXT!<545C40:[H$:[#;[C2C
MR;'+(/;A53[1BA)_G<Z -0Y.3@^UEKB[+"QN&($<L^^P G^,L.IYDHXYFE4(
M;XDCI3]00!@^=02^%L93XA:K'>CX'74]/7A&US3BP^& E0:Q.L5>"/D((P1C
M :O$1HVB^'"G7**9&_-O8-N2"_?3 FPHB=A=:'<Z_IY_:N),TSF2LZ.-*^['
MQU1IAMWRAA@8T$XYE,ZYI"27I()$=*F@BA ;3.MN31CXXN9-DS$0I%X=<MX.
M/,TKI(Y?N5KH+!\Y<CX<:"C=+-<GJOB_=V99_D&&9L'.!'5'G[L]K-*'@RVW
M!]<7[LS2 @&4W;OE@+3=1QY%+UJ%3YQSXT@']1;[X(;9*?"'TX5)&[$QXA6<
M+U3CH0V4UP@OC ZP=@%-E+"<$DX+V;EPF-^;K(G3H,WR2L5K40MHCKT]&E/!
MV>BQ[4! (HQ!IA24$YFFTC85A 6PR".;@XX%>F5_R&QPV+MEF7*&!URQO)#A
M,1Q^P= </@OTR@P#H!C-@7]17>2RGI$#IQ!VFKD-^R*:9H)G<)0$\]PU.L6"
MAT"F "9$@<>1P_3$!<FFHV8848/ /HJ8TK[J!&O96"/.G)HR6T?LANL(0Y#W
MQ#1%P+-DDG:-14>[HXNY8HY@:V&>A/7#U%SL>H#ABH,3J=1UO;UF(EK7\JG#
MV>#;9]3<K\<]Q_A"@ @ 9 &.0LT-ZY[#EZ6IH&%T]:W!Q9B[S1/7;JQ)<<EZ
M$-HE(@9PT:DTR2G^W)1T5LDZRYDHG$69K<SH-/HT?!6%J;C@TBV/>8N,'(JG
MTSK8G.E^D6TKH%2O,I',DQ_SJSKE!+VB6O,9''><I%>9$(5,8[?DR@IQ+=&D
M#^4M\IIVEBQS+#Z=4B&&B@?+YB) HZLBX[,E61$D1T>8AF(Q59I^@ ?F8)[(
MU<YT[Z&66'"\^""MU3H(-\DT>W_^\\MGT9-G+U^^.7_Z],6K7_[SA^,?Z.=W
M;\Z?Z,^RRNML4E_B,H__]CC:=<F;0B#OW^IKJ!9[G,ST:^#&'W["M3YM+$32
M!O>!H.^?_F3^W@T_R,T/$B1W;DSOY&G+SRB>1RL786>36PQ%ZZP(P 'JC=FL
MN*Y^Y)7]X_U;_!?2NK'Q6]!F>U+?!,/[/O902/>2;3/K ?580_*D4E2FB8%E
MXB.\E)X"AOQRWB-6MF?C;$&FE.;[9TG.C8BHR_7&-<!/[1>TG]Y\>!0^>]4/
M5W0@Y1THEZ4$I++3IE3)V:&7@9/<<(L;P6ZR1KBZ1)J'V:BD[T@I14'] _W5
M94Y-A GCSBK3P\CGIZB/.>F%P=)D$AIB0 8PD33 S: OYGLUP.WFT-JN9%.L
MZ.M$%,KI8'+8VX<)I ]L20&;>>'?VS(>:<W7267K=1Q?;9S8I4X&Z+AB62%N
M.R]\*_"Y+2;]S;)*V/S=&'@#28"#B,\T/U^4"OGHB47*37417PV7M1$@ Q\*
M9R'Z*$19)%AB4UP?&BBZ-2SO%Z&38ILX<;9R+RA[PL*J*W)ZL2R*G_R7K<'9
MLJ?B_CX!H@F0^_L$R(VJ&F/U;]*](E>&@X?GVO.+/G>_SA=0!P-.RP43[)V:
MN5\LY#?-N6U&G632J\:)0@@I9Q%TP5XYD30-(!EU.<D%:C7MGI<19UAGO!9E
M;3CXQF6%M\0?>+"+/_ F66F9[C-.C%6F)?J6&>\/CDSUDW-G6G0)PN7B&OFZ
MQ$6R<OD,VQW-,(K\*+2FLHG!IEVD)=EAN:_7+$:PWD2C;FY\U(*'3+"19\-B
MZ\?*<W =UR#%\Q228QP@69-MV."8D;&/ V$A=3ZA*?Z8(M9KWY!453%FT> >
M($BT^M'=P@D(_/S%J[?G\(ZQO"--):_6N_Z9#"D(']4L8&HA>L]2L+GJ0X[&
MF=;>J*H+,!(TV>8@H+S;VX$/4Q<7'.G2&!AH6[32]1-B0YP<&S.J$9BJDD9;
MOR%EYUA*K>@Q?H"8_2.$M:H^N/H9DT ,<*XHCV>;U#8"7S5 *%TX'UP.PY/M
M,%9LN87#4>8#F3Q*5 .9Y?@JI%9/:--\_7!@/E_0F6.I']2P8C?N%EV*OA4%
ML"51@,OFGA@\:LY)"]M.FM$1?2BUTS'HLV-%85C@D/0+<$C<Y(_20WZU[06+
M*-#'&0+,]>D, 5\VY<ZS<5'5+C4_3QP+(%FRW!Y;E[W!WTV*\9(AU==X\/$7
M'4?=,UMKEV'TFX?0HQ<8@,7& 5(L$<8AVM9:<+\%X=.Y1XD#ZE\TJ,^^*1U/
M1W?B,C;1J($&K0]B(A*Q&!5)Z4)IA!3\MX/+PPZ!+WO84UCC[D6\8'=)/OD'
MM=,E\P7"H1%T 9F=,:I6D@ $KVP?S,%\S[8N6JT*LUV1 *_]_= GI[J6W10E
M6.BZS+%MH!*DXP^'5C#-T@O,E_;(IPX8^*:$8<NB+K!A*9GCN]PG-V(#-OJ#
MJVA_GV:U43:!S@)+/?H/L%3CX^/CMN/!$R8F2W 3'.D"&"6M>5'UK,MJ](=U
MV#W,)HZT/C7 *3^):2V2K!7_:'_3$<I*RJU6OD=ORJ@>7:5$'>08I4EISD"P
M[:"LEJ6/U,S[1+DMI#7>DV/(Q#3,@\"=D<%3LZ%X@YR=#9&6!_M(BT9:'NPC
M+7^"FJ<'-O82'/VV!R=R)+3]?7&]$R[-_.4#&R]^Y.8%M?*_%$@!H4I]PE,=
M!H0UB4VI8_/JZ[115GJ3E6(PY(TXM4F:,J*I RJ>#,*12*E+8!40;B22YSXA
MGDPHQ$ BV[U5!)^Z:@ZR28HM46,@EM,-DF??A^?NVGZI_([:"* <N_CN=5=@
M0+:A=R:H58K2GIUTJ<>8T:%0C9,#)9I\..A2Y<[33L!$"-:M/(#,6UQ32")%
M5X(!TK"P9W5GBMU#EV";@[K$TC\N1$O+,14O'1\]N/<W!_QY 09QY=Z/#9J[
M-ZJX(MMM>U.Z)JG>>EX]ZXANO4VSN;-2PQ!71Q&6EX.FH9*AHUWMJ,%@,[NK
M L/9P?  C?1POWQ;-MZD#?LK1(8?[E8I(E-TO?4?1"375X\4:Z^E9(3#.&F?
M<V=/KT5E-4Z .!-=<=?.SC5S+S>P\\UKQ7!;H,2^IL_D;,@/X!E3-JS;1ME!
MJ\"5U'#\D"-NEGBX.(J!2"Q,YNH(3;G.AL2X7[:;?WP+ZV\>VA!^"#GM)QJ
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M$)6U3#!?@BS ED>059BSBUZF-6:OUX<S/T5,TINB\YD,7'[Y\HTQ$(:#5@-
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M(7$X]-N^TEU/=OCR6H?!9A7&@3>X:"B5FUO-72&R.%S).$$@C!D-_<9^%A&
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MI(L;-A;/6)J ;#;)\1?3EC:.K2YN"/HU99A9?H6BD-,\AZ :67]3K=_<YP!
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M(90DB?B?ZOIA,D+J7U9>5,ME6_]J+P%ZBWU_PVR]H/CV.7W&-(**'R1%QG
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M'_ C$F7'GZ<#!(96[P3^6S5Q/V7Q:7 436;]>#RFO@FHU:)N?JQ.Q%RQM+K
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M/O/'8&849S9*CQ6VL4FSJRP!0&VR&G4'8S!Y>IC12+??ZXL6Z=@#N_[@+$L
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M]^-!O(X'W^5'H1W?L*Q7?>;1&0!DO,$2#T@;OB<:SB:D_;7L_+4>D_2*(Z*
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MLQ84Z\:V>E'Y.7T_ >DQ(S$LK[KA%_)@[[XBKR+.<' \\7U.EFYCD523$WZ
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M [NE2N5_(M_<&.?=Y.S)PO,P,N>23LU:V1[O8(TW_D <[*L3\3:;Y7!M:9.
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M3)7SZ9JP&U>N=->4*REBD'GCE>/NF<I'87CZ?E#LG30&N#:L\M(5L6X99F\
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MWP4JN42MK,YVL1BOHX,07T0V"W9)K;[KM24)2Z.A ]\6:]1_-4H,/([?Y;
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M"CH&8-DZNR\Q-<RD1^+=82':4:QPQ<^/S\Z1+\[J9!$Y4,5.FB6^OND4)UE
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MNEVTY&..@Y:M0 '0,!2.PBJW64G9?,;41V&2$Y0?F<^QLN %T\&ZG81.=_\
M]FB<E]CD_6V5I-'+["(KHOO1]\EB^2CZ(8[^\L/AC[!U,-MDB8&&_?L__OC@
M,(Z.L5H7YP)Z;3Z#<SZ+WF1(E&=SA#,]I=I5=*F]9E]A[ +K/1P._OW]7Q[<
M_^'!H__$.M&7M\E%X$-A:,#X;/:"G%GJA"UWCFJC-UY[=7"RE7M1X(Q8%3X?
M<$ALI'T^)!^ZV1PP_]#=-IL=J1X1!N"0%,G=/M(J34 )188ZM/"RQE7US@?=
M9%(*E<,$].@7H)"X9U1;Z=0&OI-&HMSQC)MZJ;YT5,F)TT'/IPA4$H<V*E?E
MSR9OK"U )YJB2) ^;M65 T(,3,@$J>\]/-R/EGN+O6A'.7_9&XR3)%!84N>X
MU:'JV45IZW;#-@-2TK<V\?9\Y,5%H;5151B6!:B>MH1^I^8[')RP9LK-S"BO
M;CLB6 N.)?!-/G;L?9,ZY'#[)2H@-O&'\DZ3G@ 7A=I=7ILS(KYC?C&29N!<
M.>O5+[%OC+!>JX5SLO(F<A,AAP,ZP5N#^9F;\+%@_$P"0Z6Z)7]>_+[(AN^[
MV3K*5HZOPUO'E^?X.KQU?'TS1_S>W@-=4:KU7])Y7^8^/J!KKJNL#HF;$G:!
M2>##D#/QMPM=TN!:7?U^@\K*V@\5>&)E<;E:J/[="OAUZN3;44?F"^"%,]-L
M6QFWS#>1T6,_YLPTW9,%N\^C>)7Z354$P WA9*4=0-[ZJKKR6'<U(CYMQLT;
MB<UVE5+,> &9, %)E6/TWM?A;C:COK=WL&_\MVQI!WVW=%P1JT)A<W!$-PA&
M:V%?2C5DQ/%"V^F 2@H%9='QQ[Z46/>@M5\K\(23X<!+=S7^@BLKA^Q8[*(J
M,\9C%P\.)XFI"LT4F_M28_$%>EKXJDQ%I<"R:-<=PGX6QAI 1@S'$J/FNA"C
M/ZAIIQ^H^57LHY/;:N<<D!(H.3#LB@(CQ7115T1R4H)9^6(/"H6T,5V'5VNM
M]/8&Z.)'W72N87_U,>$56NYJ"Q?+JOKR_*!Q=YLM!DOA8RLIU#1_E;,@\)HE
M>[R9@4KO.>:<M'MCW3! #%3=LIB'T+%Z 5WL-(Q0T]KF=]+NDOG!IA-=<R97
MF>KZ*)7MXZQ@K26$#TJT$0Q+90LPFGH'#]:(#%?XW1YP7;AQC&41F%/7!UTL
M":6+*N5D&N1["]Y/A>1DME^2<:2L0YM+"LI.\H Z,ERU3"VS:$[XN91!D<#8
MOU$=*DQ_E_(!Q>6A?)!N36UC7D0: ;Z*%"V>NW&_)&K-A)WA?-EAT;PB3H$'
M,LC*J/FWY, H?\ "G8'3Y*+BWL6ZAP@?PIUF9)W#+CBO@.,0S!9YSD*_(J]+
M9V")0ZCJ/4+T<=K1XTLU=*\"RPJ/<'LS#(X$]1/MX'K_BB<"HS!+D/PY[1W)
M^"V";SJEU8(_E+U,E"?5^/J0SU&BL.@R;E%Q#.QNU4H/NVT&AT<(29N5% J]
M;'B[S@24UUIK,#/4W0'8LZ,\IFHDN6TR#J4[J_B ?);H(ASN9)!:$5A;J-36
M,Y3LU2MP;L^OQK?X*2/7H:^\S^5C+*_I=M! >:T$M,X09>6:>B[S/TK5<E<5
MX\5:'Y9H0VPYLA,=?__(.W4%V%O74_/1MR@\R/\._-\G'O*SK.MQ_N3?3\^?
MG4<O*($1=ORMR;A]4V>[V%<8_C0%^M0M -56\@X])P=V\Y_'=_(GGY4>5[@=
MCV[=CI[;\>AFNAV_W;OU^>_41QYD8_W7BU?1KR_.7YV>G46__G3Z]O3U<R=Z
M,QQ@6P7J;R=-%3;23FE:5AL1"^1&Y2!AKRP7/42 VG3P;9K76#-$I;UH>V,U
M^4?L(_"%Z^,.>Q4/*YBS'6JM8@_,'S%!*%DVP"'47]OCLCZ*!%>6$' )BW83
M6JT[_2*;MM\1#WG<IIIF\*=\A/.!:9=__^[N=T_@+D8G+_[QXOSX9?3R_,2"
MG_V$@UI??X*AGCQ=/W2&=O=E@]SZB//R\('OXS8&J.(^=0\>(AEUY9.'^*B=
M?O/)B/FB;1QJ/NE)\W$F$$0N_N2W].-R(J;,)Q4&/,16(>-[M[J;I[O=N]7=
M/LLA)>^]PBPW;<H.E+W]:8?]/$KI^,FKU^<OGIU&KY]'I_]S^O;9B[/33[BV
M'DWS6EK&1W8B./K&=02(9L-!P/PNVQ:>9T-<TM<,-P3,YF&T6BZS&E&2OWMR
M7CT4.,NM@/6#V@S)HSXX_8^IM'X1T^$ %>.=@Q%&?8<#<G)*SQN)JF68IM[8
M.1+1_Y/_ZR#">UCV5LI7ZT(K9::'H48;('=9/C4XO>3&QZ($@:RF\)BD5%/,
M1$$>RBMU&)V3)72G.*]C$&(X&2^NV]0P%D_QYS5/#CZ!<;+]WM\=@5@D0@X'
M@IR/T$A2)+N@W%G8*1#T%MG&U?O1PYM#I#^!)>>Q5H><O7:",IS_\N"'HR-7
ML4?4]>02;ACEA1A0L%]*"IX02DKSR>S!*S[Z)"-VB;!1F&#_1IT30($"%U]?
M)67W@2@E#:5/*X2BN ^D!B_IJDC<O&QL'JO[9!S&_;EO^!I$#..@J'#J1?(^
M7ZP6_7,34> UQI*V07Z9*-=$I>B#VS#'O4]F 7[UW 7;CKXI,DH_9*PXZH#G
M=R+K]JNRQ357B5G5,/0@'R+3J':<%=7E+>/^\S+NJRQT/:^[KD]T,Q_]TUY'
M,!&ZA?16B9&JBA'>IFM+AH.37X^?1<? CQ&G\A4QRD]\KSX716[OS$>Y,]^T
MMO-!3N];8ER3FW[+?,+GV-< =;__N5S0KJ?U+P?W]Q_=(.?NQHWZ/([1+=UT
M_SY[\8]7Q^>_O#T=#EX_CWYZ_?+D].U_M.?NRSA1;1GGRT!/O("XNHZ4ZQ65
MB@G5ZJ08WN,S,3Y_6C(=W?M;B*>]$F.!LR4P)_ 4"T36#R/-HZXI"8/,5,4?
M_4ET&))A@M=<9G_0(K2,[;W.6T],=G\7!T>_R,%=XYI65VM7?[S],A[G3TR*
MBMLVBC^ON-+'WT%,9'GX43?Q3[IQVT],79;0%GSD"W/C:7U.G71OB?U9)H;(
M5U^,IG\*97=+Q?:'6\7V,RJV7R9QX6CO_I\K=>'X#+7OGT]?G4?/7[_]^?/G
M+7S&#-"=\TK*,UT08(V+AU4ZE._*41(*@#+ ]')9K UTBP6FLA>=5%1-MFKL
M7[D1ERP$-N 7\N^-_@19L=<8&8Y;],_CE[^<1F]/GYV^^.?I2>QNBT%C4+!;
M4@ML:G];50A>9[HFO)&02%M]!?3\1@W*N_LJF?136(I'@7S6D./6?^Y#-*+O
MGAP+=-Q'7$EX]G]\JF_F6-VKPPE?_7Q/"1I,$?ACZIB?:L:D#'\#\_20<[63
MX!N<^Q>^?Y_8 OG:I.K7,7+ 5@D;46]71;:KC 7;:'%32JTOJ*5YD_^.%I=E
M.)$ELR$F@W:*_*]MISCCNQ0+S?P.=@.C(,Z\711/_C]02P,$%     @ RXB)
M6<7!"_?^$   Q6\  !P   !E83 R,C0P-#,P,65X-2TQ7V)T8V1I9VDN:'1M
M[5U;4QLY%GYWE?^#UKN3(K6V,29< H1:8\B$&B L=B8U3UMRMVQKTI8Z4C<.
M6_/C]QQ)?:4!D\7)#'$>'-S=DHZD3^=^V@?OAN=GA_7:P;N3WC'\3_#?P?!T
M>'9R>+!N_X>[Z^[VP='[X]_(8/C;V<F;QEB*:(]L=,*(#/F,:7+!YN1*SJAH
MV@M-,F"*CQO0$)I>/K;=/IE1->&B%<EPC\#CZ861C"(Y<]<B]B5JT8!/Q!Y1
M?#*-&H<'1X<G7Z9\Q".RU=XX6#^"N5S^GU14C/9[K",^OFD<OA C'>XO=XRT
M]V'OZ.R$]$_.S@:7O?[IQ<]O&IV&^7[9.SY.OC^:@CGWHRD^VOEIGXRD\IEJ
M>3((:*C9'DG^:AB,' ROD@&NF8JX1X.$7MBKAL/1P? X><IUOH-]A]3WN9BT
MS%[MD6Z[NX631DI;FO^767+=A3FS3XUDX,,:G)[_3 97_3<-]F6KM?&?3F>C
M_7LX:9#>V?!-(]N'X?&=)&QV?DKI*^T3CO'8S6H<]M]?_'9R-2#'IV=GY 6=
MA?OD\J1W==Z[L#M6-=*C!^F^/AA\N#R,I@?K^#]Y&TBIGK#_]X*1DR_>E(H)
M(X//,57L"7O?)7TI!(UA)\EE0+VG[+O/1*1H\(0]OI-B0GZ!CR?L<TC^N;O5
M)=VM[BNRL]'9)G^0M^[2[JLM\KJ[O7OW:%^'2T^*&Z9TVY,S[-H<"OBXL@=X
MW7"1P[\$0VP<OB;'S&.S$5.DV^F^6@JC=:)CB:S<C7!.HP@F<B';R&Q?[6QW
MESG:&H#L):*L2UYO[7:6.=35#17M<P_.^C6[^5<)?W_!_<I$[]'AT;!/COF$
M1S0@9Y'?)LM7*K8WH.6("RT%_$%]<L:N64"VG9#96>[H?]_9W(7'05#34"I&
M.MN[NZ\WGX$:=71X!2K&K?U<BZ:,O C\S['<[\M92,7-"V6^O7P>^N-'1J;T
MFA'J1<PG5!,=,H_#]/OT!CHDISJ@PM?U6L F<-63L=  MT@27!FW)(0+N",$
M\R(.L)SS:$HH">-1P#TBQV,@!H1G?BUAO=^[Z[B.R9IB1_C4!\&1G$%$(YB>
M'!.@A$XF"FB(6+T&%];X2[*[VVEV.AT"6BD75-T0/04-!68?4D6N:1!#1X-_
M=-H@6!GUIMA/GN@2/?U :B1S8#K)4[4/H\%P&\WMKATP5*PUCH7/_'IM3I6B
M(M+E[B[AF;?F&?+1/9+K$R;D6Z+HO6T*BP.+'L8*U#'-<L0DLZ_7'C=]]H4I
MCVLZ"F#W(UQA=X7!_+C'\'G;OK-!0A!-IOOR-!V=5:M6K^$D8>E@[>(0J=_<
MV3(DHZJ/2 % ?>7> <'X588&<.[F!U@Y-5<<Y>@:0-EG8RYPCT8LD/.7MP!H
M&]^BW.Q-)"<,'E<6S&;H CZ:I +-%:O@-AF)T9[B(R3'@?R*3;@&+=52@5"?
M@=9J1X?;ETKB68QB@!98MJX3,R-B)]3^INPG,S#S!F79X/QX>CQ\]Z:!]N)7
M6)L+6/; JQ\T,V_;=YV&4W5OWVEO<6$$P$;;LO3B8Q5+<\M8[8"QZCHY?M__
M<'YR,1R0JY-?3T\^GAQGG:*:G:G8?V6I\58J@U%@1Z'4ED5/^#4>CVC*X6O(
M!:"Z">S1R1?VA<X,=#VX9QM@!V,9 )*QG2^]&/&O]U:H?C)4;Z";ZT$\-PYS
MK/6%TLBX-%%Y]J13]@1?8/=G9-#:)&MO.0@/-%DV-S=;W=W-S>T=RV;KM8PU
M)H\7V.(86OH9<QTP+P;&C<A _I<Z'8"H&=<:2:A4#=:R808G_<((T*3;J=<N
MY'5F(IK.?>8%P*9!_@+/!HT%T#FZL52<]+'95M&N+,N-:KY=$'W?\;P_=T!W
MOQK08290N?""&-6L^T6Q3Q%JMU%4 L01*F29N"Z@,)'FN<%U'(9!?H#7]^,M
MZ[E>&Z1M<Z,T*[25$DUE=>4.:A4+8 V0BUO]/M'1$W:=UW*L>F<UE5NJ[NH$
M+.\$;"Y\ N)$(<8MI& ^6=3-J \J_PP=FCT$/MAZH3%Y^U*%[3+\<EIU'BO9
M]B<ZN07S=A',351;*0R+Z'!L=LR5CNQ%0X\#V\/4EI5\H*!>NTW"K?.$80K+
MZ8.;\DGXD!^UEXSZ9^'FRXT9_:W5(F\Y"_P]<DDG;!^Z^!PSX6&PA;1:B>/Y
M^/37A(P\[C>Z%<#?QFLN3I1<.PJH]XELM+> >"T#CB&;RV*/[L1DLS]8AU$K
M"!@I1C^U1FPL%5 9&JKS1&U7T(2$/G;(W-*LX]K8Y5AQL"?A8*\6YF 5HH6
M/AAGS"0Y^L!$/""1<M04KYF.I-+6^'9,H5XK<(65A%K>_FXMM+\4;<&;1+5(
M9 1*%= N(K-I,S:3L.E^/#/7*9(8.(^@UM+C-.?_J=<2+" 0^)AG(-',4RQ"
M-U/)CP2-']"^SHLD]'(D]#(2_BSRXKDC:WLA9&4^!A3L$1.(*!G$N%.IZ\'G
M"G0"Y!*)FD]NVXJN?;U6ZJ#<^$&3,6V]0LJW0<K.@CRH;WF%!]N(&_NSE,:Y
M(-"_5Q(UB96H\$'+01!F7#B[20).2H&1A[T)^?&/X6.%CV^#C]U%951N?S(X
MT)0#5$B4!W;\V+4$>97U78PW ?Q66[^TK7^]T-;K&,-.QJN2^J:-3# &J;G+
MQ.>8*^.TU*B @O&D4Q$1T#E>=@[P>LU'R](G J"A-:HBP#>,G80M%2H_RL6T
MC.\<=):(@)4336VTI[T"Q/)"/]U%0S_FZ=Y@\.'\<GCZ_F+P'(,[:4H <#M
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MGD6-#6_.,=$%!I@+/"<R5@03, 6*[Q4HEP?*Q8,7U/-B1;UJ/H-[/:9>%-,
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MT9XY\ULLSH)\#SU75#AVHVG JC(Z2B&U)BE%^)-,&LQ@!=FL6-)AR!0J=68
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M)8LRJT7K >)*Y49P*5]<U 3RC)F2S->6I5BMY!85W*5:,N?2#9F@@;%JLX7
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MT.]SBS/7FN#9CX?<&A(*>H-:A)[,^ML58X?9 V8GJAE%Y4#/V!>.(\;^^;L
M]\"8F4@Z-3.1:&AJ*W&8T,18B/W4QFP$Q6<*#P:BA0A]+U6*(A7B1Q:X+;^;
M'(,/<'<_#]>B01H/%O-4.@7HL </P/*=1_Q".+-/!7<=[@#D$85P!O_[ 7P%
MC"VFT6?]/K-VXJFVC]:A0<PA]].IA7P(UDX@OP#\F!6@I@$,E@C0YZ%U @\&
M2O9HSV,.$/4P8P (44F)@/2:N]2!;"4 1P"79Y.5&##,,197*9%.P3?AACCC
M"?EP;*$#T-$!\IA'&2(9;>;P'W"JX),X)7UJ^7S$'08BP@$ZY!-W+2>P\8C;
M]4N0"XA/"'/@#*5PN45\P)>J0*(K&WG.!&:F4V,.%J5UQ.@:I,_0P3FDT6U>
MM4C54KB98J%0 ";&P,B2\7ALV,(*D)8!9#XC'YU($26IZX^X[X-[A,Q)#06X
M.:K#Y22.*?%%;"M3:-*I&39$IU\]3/C JB>1$^8V?'Y<%^:%X868ML)5[;[Q
M'+Q >L('M_#+!=L_(:_NSD[+HP,6Q00#4^F_WD5^&9'_3RY'+CES['/2AIV6
M@,8_ 411!JQ(+C<MO\OUYO?Y.C>GA =3BMZL4L[UA%)B=$Y.<*PG)"CS;.S"
M@0 ,.=JQAQH(6@,B)#J@4, 93<VED, $QN)0E?,@88*P/<GHW[D> ZV$'7EZ
MAW'2)PFD<5-Q\6)PKF09@S&/.(;0_>(ZTJS\"46?N2J /;KQF;6D4[CYO\**
M<\^M)#'L/17,BD>HOIE*,RPM4*4& B&!"A@+6\L"G:=@.D2[]8D() D0.DBC
M7(P,D+9Z#J-0\@));F']HB?!2L@D]$I=M@"]Q4 )J1DZ?<TM3,!\C\)\3XH?
M'!..'@,'M457:U8O;AJDUKBYZ;:KM6;KZFNFD-'?V]5Z/?J^,=,QM]40IQ8^
MS'R&!<Z6>C[8:_0IH\VL;'8B!A"%% #H1.<'MIR)3-&LSV0WZX^#I':+HK>^
M9HJ9RG<F)Q R,<#A"?A9/1=^==Z:4VS"-LA#8:C[,LTK;!20&[-NA(7A K]G
M:#X[F$PKVL7T%$\*'S+)(J_>[4P%CC^$26?.Y_^R4'DRE8O)>3*EY\)+B3S%
MZS"16=[/HR<+*.9PS!UL"N*3NUSBUH*<<\7FUB.P.U%-KIS7R5H;<M:'B@G3
M?$P2;[%89W)![+QV,GN:*\(FA-OG<C1-?T.G'5;'TV83MFM)7WMNVA.P38R9
MBKF[:"6\F"!XD&KCJMDEM6I;^Y#:;:=M;+>[M!_!Y&7*''-8K_)/4*0JEM-1
M_)RX8BRIM^RTPO6K93A$(=!O=40/EI(&Y +) JUPT>O$I%"(S#+-37S:TMR5
M$F]/O*?\V$8NZQE99WYL+^U]C<JO6"*W'C9:_7.DV\727K@E\ITZ 5[>56$8
M;M(5<D2=C7/ZC2K).!H1#B5B3CS8;E72'K=*1&NWQJHE$('B7-47K<(K[[HB
MW=TMCV[MNE&_@TB!C>M?_59R;%]MR2VLY.K<MQSA8Y>I#5: A[3[73[&XGCL
M78S-\V%M.:@N!-]-'L-8P[F#UP!\!E) .8W,A3PG<M#[5"P<98N'I]GB\?'G
MA  P%>GT%&)>*]"WT"%3JP'DB'YW2"7SPW"PO.C@F5)F-FT>9(?UU7R 75IR
M]B'Q 9'3TT*V4"BL%.<Y/FM'RB0P[S$924!PF>4RCFW)<OU W_6XIU)25SV"
M^B2$Z^*6 -9!]J28"-<6,7I"X6*HA'%S4;FVAL/QKE%XB:9,,?D9BE(L'N^1
MFK2#GL,M3"7!^6G3X=C# Y3FG-)+4?GO&H"<&GNJ+L]CLZP_VP3JBW%V=K8G
M>@-5B+3P4:E'4!",RYV!40"M.=A+M9F[-X$)%=[J#-5&C$:1)]8=FPBVW>E0
MP3@^V1/?\X2?%FX.[UT ;OI)&_;@,1=TC>(M3WU38F_0+.P4S44E!!<EK2&=
M,\-XN-^N-SH\W7M-6HW/;KT5@/7EI:Y[SWO0ZW1O#G\W:N8;-8>_&S4[:M3H
MYPEW\\+!+&-F5H#AG_F[NF>QOWV2!"_]PAL1NAT^9NA/D;ACQS*MZ+Y=K$FQ
M%HD2&)&-ST$\FDOX0,5S=[G?>B_).C6K5\L7G<I"EX@HH4<O6"AK%.GLM9!(
MW'8BQBL:1^\.7I C7M6%0PN] 1*.*@&HD]^ OQKPN<X4/ND9CL?!);P?H3YD
MY!M]X*-@-!VY!9>3JT)-H/0#2=/!D&;3G_*("M5M'M.V\]KH3NE10LMUY9$G
MO ?U1"=W$[U97U<V[TBO3?3%/>L51[QAR_P]8;:R=?T;M2=0._R2V,=]+69)
M9=^J5R.B,F73A'+M9YCWAO6;LDD.3D=)A6PG<%@N*H%6%:PKV<02Z\S<ZE5(
M1H][Q(I=S2&ATHV0PK)M^CM>MLT)ON*M\"6X\_C>>D6_R([ON_\?4$L#!!0
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MV81_#5.,1PT(\:E%-7UDQ^%3OQ<O3YO+/CJCH7(S+BCO9_.-.#2B&I?1DXT
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M,%>:&V,C1O=')$;\]A&H/QP=LP:J@#YD$=>*_ZLD39 [A[A71)6"P*!R52W
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M4"V.7DQ:XMCI&B;HX;!Z>#(>,^+6NP^G]^Q>]Q>;UYX#ZSSL WN14"=1"4\
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MYRI[O+L[=8F+50D0H?T8K0L>9G<?[W:[_/?6\ =8_COM?P%02P$"% ,4
M" #+B(E9QPSXTK0#  "0#@  $0              @ $     8G1C="TR,#(T
M,3(P-2YX<V102P$"% ,4    " #+B(E9GVGQZN@(   ):   %0
M    @ 'C P  8G1C="TR,#(T,3(P-5]D968N>&UL4$L! A0#%     @ RXB)
M69:&%%V\"P  YXX  !4              ( !_@P  &)T8W0M,C R-#$R,#5?
M;&%B+GAM;%!+ 0(4 Q0    ( ,N(B5EVLT$^,0@  *-B   5
M  "  >T8  !B=&-T+3(P,C0Q,C U7W!R92YX;6Q02P$"% ,4    " #+B(E9
M]+)A#K<=  !/I   &               @ %1(0  96$P,C(T,#0S+3AK7V)T
M8V1I9VDN:'1M4$L! A0#%     @ RXB)65T/,]" H   ;]8# !P
M     ( !/C\  &5A,#(R-# T,S Q97@Q+3%?8G1C9&EG:2YH=&U02P$"% ,4
M    " #+B(E9#0PD;49.  !"I0$ '               @ 'XWP  96$P,C(T
M,#0S,#%E>#0M,5]B=&-D:6=I+FAT;5!+ 0(4 Q0    ( ,N(B5G%P0OW_A
M ,5O   <              "  7@N 0!E83 R,C0P-#,P,65X-2TQ7V)T8V1I
M9VDN:'1M4$L! A0#%     @ RXB)6:%J0PRF"0  ]CX  !T
M ( !L#\! &5A,#(R-# T,S Q97@Y.2TQ7V)T8V1I9VDN:'1M4$L! A0#%
M  @ RXB)6;DV>45)"0  C1P  !T              ( !D4D! &5A,#(R-# T
M,S Q97@Y.2TR7V)T8V1I9VDN:'1M4$L! A0#%     @ RXB)69-PO.97"@
M62$  !T              ( !%5,! &5A,#(R-# T,S Q97@Y.2TS7V)T8V1I
M9VDN:'1M4$L! A0#%     @ RXB)6=9V<FI@"0  KAT  !T
M ( !IUT! &5A,#(R-# T,S Q97@Y.2TT7V)T8V1I9VDN:'1M4$L%!@     ,
-  P 6 ,  $)G 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>ea0224043-8k_btcdigi_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BTCT="http://btct.investorroom.com/20241205"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btct-20241205.xsd" xlink:type="simple"/>
    <context id="AsOf2024-12-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001796514</identifier>
        </entity>
        <period>
            <startDate>2024-12-05</startDate>
            <endDate>2024-12-05</endDate>
        </period>
    </context>
    <context id="From2024-12-052024-12-05_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001796514</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCT:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-05</startDate>
            <endDate>2024-12-05</endDate>
        </period>
    </context>
    <context id="From2024-12-052024-12-05_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001796514</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCT:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-05</startDate>
            <endDate>2024-12-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-12-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-12-05" id="Fact000004">0001796514</dei:EntityCentralIndexKey>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-12-05" id="xdx2ixbrl0014">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="AsOf2024-12-05" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-12-05" id="Fact000010">2024-12-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-12-05" id="Fact000011">BTC DIGITAL LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-12-05" id="Fact000012">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-12-05" id="Fact000013">001-39258</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-12-05" id="Fact000015">61 Robinson Road Level 6 &amp; 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-12-05" id="Fact000016">#738</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCountry contextRef="AsOf2024-12-05" id="Fact000017">SG</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-12-05" id="Fact000018">068893</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-12-05" id="Fact000019">+65</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-12-05" id="Fact000020">6022 2515</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-12-05" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-12-05" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-12-05" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-12-05" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-12-05" id="Fact000025">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-12-05" id="Fact000026">false</dei:EntityExTransitionPeriod>
    <dei:Security12bTitle
      contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember"
      id="Fact000027">Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember"
      id="Fact000028">BTCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-12-052024-12-05_custom_OrdinarySharesMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-12-052024-12-05_custom_WarrantsMember"
      id="Fact000030">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-12-052024-12-05_custom_WarrantsMember"
      id="Fact000031">BTCTW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-12-052024-12-05_custom_WarrantsMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
